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Over the past two decades, studies on the cellular response to very low dose radiation have been 
revolutionizing historically-held paradigms of cellular radioresponse.  Indeed, a host of 
seemingly contradictory events have recently been reported to occur within this dose range of 
radiation exposure which make extrapolation of data derived from high dose studies to these low 
dose ranges no longer a feasible alternative.  In this study, we investigate the radioresponse of 
two human tumor cell lines, A375 human melanoma cells and PC3 human prostate cancer cells, 
which appear to behave quite differently in the very low dose radiation range.  More specifically, 
we  (a) characterize the cell survival response following low dose radiation in the A375 human 
melanoma cells and PC3 human prostate cancer cell lines; (b) investigate the kinetics and 
magnitude of cell cycle arrest that occurs following low dose radiation exposure in these cell 
lines; and (c)  ascertain whether signaling through the MAPK and NF-κB proliferative pathways 
is being stimulated following exposure to low doses of radiation.  The results of these studies 
demonstrate that two different and contradictory survival responses are seen following exposure 
to very low dose irradiation (hyper-radioresistance in A375 cells vs. hyper-radiosensitivity in 
PC3 cells). Furthermore, the data indicate that differential regulation of G2/M cell cycle arrest 
may be involved in the contradictory survival responses observed.   
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CHAPTER 1:  INTRODUCTION 
1.1 THE PROBLEM - INCREASING EXPOSURE OF THE WORLD POPULATION TO 
LOW DOSE RADIATION 
 
 Since the discovery of x-rays and radioactivity by Wilhelm Roentgen and Marie Curie at 
the end of the nineteenth century, the use of ionizing radiation (IR) in the medical, as well as 
non-medical fields has been on the rise (1, 2).  Many reports have been written on the biological 
effects of radiation, especially at high doses (3-9), but the effects of low dose radiation (defined 
as 1 Gy or less), and especially very low dose radiation (defined as 20 cGy or less), still remain 
largely unclear.  Nevertheless, exposure to low doses of radiation has exponentially increased in 
the past two decades.  For example, with carbon-based energy sources of the world depleting 
rapidly, many governments have turned to nuclear power as a source of energy (10).  If this trend 
continues, an increase in human populations exposed to low doses of ionizing radiation from 
nuclear industrial waste and accidents is a realistic expectation. 
 Additionally, the exposure to low doses of radiation in the form of x-ray procedures for 
diagnostic imaging is reaching more and more individuals throughout the world and with greater 
frequency.  Furthermore, ionizing radiation has emerged as a primary treatment for many 
carcinomas, either alone or in combination with other treatment modalities (e.g. chemotherapy 
and surgery). Whereas methods of radiation delivery such as intensity modulated radiation 
therapy (IMRT) and image guided radiation therapy (IGRT) have emerged with a record of more 
targeted delivery of radiation to the tumor site, these protocols also expose larger sections of 
normal tissues to low doses of ionizing radiation (1, 11). 
 Finally, the threat posed by the use of nuclear terrorism within the United States and in 
many parts of the world has grown significantly in recent years. Indeed, one of the unique 
problems of the twenty first century is the emergence of terrorist groups.  A nuclear terrorism 
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attack can expose a large number of people to low doses of ionizing radiation, as well as the 
more lethal higher doses often publicized by the media.  Certainly, therefore, biological effects at 
low doses of ionizing radiation have become increasingly important in the present era. 
 
1.2 THE CHALLENGE - PARADIGM SHIFTS IN OUR UNDERSTANDING OF LOW 
DOSE RADIORESPONSE 
 
 Because of the central role played by the DNA in cellular function, radiobiologists have 
traditionally modeled the response of cells to ionizing radiation on DNA damage and repair.  To 
model the observable effects, ionizing radiation (especially photon irradiations such as x-rays 
and gamma rays) was assumed to cause two types of breaks in the DNA.  The first of these was 
the single strand break that was easily repaired, and the second was the double strand break that 
was much harder to repair (12).  It was assumed that low doses resulted mostly in single strand 
breaks that were quickly repaired while higher doses were dominated by double strand breaks 
that were much harder to repair.  In brief, proponents of this theory assumed that a threshold of 
double strand breaks was required to inactivate a cell, leading to reproductive death.  Ultimately, 
a linear quadratic equation [ln S = -(αD +βD2)] formed the basis of much of cellular 
radioresponse (in the above equation, S is the survival fraction after a dose D and α and β are 
constants).  Effects of radiation at low doses were simply extrapolated back from the high dose 
data. 
 Currently, however, many radiobiologists believe that the DNA centric modeling of 
radiobiological effects may not be completely valid.  In fact, several reports now indicate that 
low doses of ionizing radiation may have profound, and perhaps lasting, effects on cellular 
metabolism and cell-cell communication - not only on cells that have been directly hit by 
 3 
 
radiation, but also on cells that have no direct contact with the incoming photons.  Specifically, 
reports on low dose ionizing radiation have documented that radiation in this dose range can 
stimulate signaling pathways that are not reliant on direct DNA damage.  Indeed, scientists are 
documenting a host of previously unexpected and oftentimes contradictory responses.  For 
example, following low dose radiation exposure, observations of bystander effects (13-15), 
adaptive responses (16), hyper-radiosensitivity (17), genomic instability (18), and hyper-
radioresistance (19-21)
 
of cells have increasingly been reported in the literature.  However, 
mechanisms by which cells translate the radiation signal to affect cell metabolism, proliferation 
and even survival still remain incompletely understood, and much debate has centered around the 
fact that these above-mentioned responses to low dose radiation appear to be highly cell type 
specific.  The following sections will first briefly discuss some of the cellular responses known 
to be induced by exposure of cells to ionizing radiation, and, subsequently, will present a 
summary of the newly emerging observations and evidence that are rapidly changing 
historically-held tenets regarding the cellular effects of low dose radiation exposures. 
 
1.3 MOLECULAR MECHANISMS OF RADIATION-INDUCED CELL RESPONSE 
 Cells have evolved complex mechanisms to cope with damaging agents such as ionizing 
radiation.  These include the ability to: (1) halt progression of the cell cycle (cell cycle arrest or 
“block”)  to repair DNA damage prior to entering mitosis and cell division; (2)  trigger 
programmed cell death (apoptosis) in cells so badly damaged that genetic stability may be 
compromised;  and (3) to upregulate  growth factors which stimulate proliferation to replenish 
lost cells (12, 22-25).  In the sections that follow, a summary of these responses will be 
presented. 
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1.3.1 Cell Cycle Changes Following Exposure to Radiation 
 Dividing cells go through a cell cycle consisting of four distinct phases: G1, G2, S, and 
M. Quiescent cells not undergoing cell cycle progression are designated to be in G0.  A 
schematic of this process is presented below.  Briefly, in G1, the cell increases in size and 
synthesizes extra RNA and proteins; in S phase, the DNA is replicated; in G2, the cell makes 
proteins necessary for cell division; and, finally, in M phase, the cells go through mitosis. 
 
 
Figure 1.1:  The Cell Cycle 
 
Progression through the cell cycle in normal cells is regulated at various checkpoints by a 
group of proteins known as cyclins and their corresponding cyclin dependent kinases (CDK‟s).  
Cycin kinase inhibitors (CKI; e.g. p21/WAF-1) are also involved (24, 26-29).  While the levels 
of CDK‟s stay relatively constant throughout the cell cycle, the concentrations of the cyclins 
fluctuate greatly from one cell cycle phase to another as demonstrated in Figure 1.2 below. 
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 Figure 1.2:  Cyclin Levels as a Function of Cell Cycle Phase 
 
Cyclins must bind with their corresponding CDKs to activate them as demonstrated 
below.  Once formed, the activated cyclin/CDK complexes phosphorylate particular proteins 
involved in the progression of the cell cycle from one phase to another. 
 
 
 
 
 
 
 
 
 
Figure 1.3:  Cyclin/CDK Complexes Throughout the Cell Cycle 
Cells respond to DNA damaging agents, such as ionizing radiation by activating cell 
CYCLIN B + CDK1
CYCLIN A + CDK2
M
G1
S
G2
CYCLIN  E + CDK2 
CYCLIN D + 
CDK 4,5,6 
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cycle checkpoints.  Halting progression of the cell cycle at these checkpoints allows the cell time 
to repair damaged DNA before proceeding to the next phase, thereby decreasing the potential for 
genetic mutations (27, 30).  Numerous reports have demonstrated the existence of ionizing 
radiation-induced arrests in the G1, G2 and S phases of the cell cycle [reviewed in 24]. For 
example, irradiation with high doses in HeLa cells, a human adenocarcinoma cell line, induced 
delays in the S phase, while moderately low doses caused a G2 phase arrest (31, 32). 
 
Figure 1.4:  Cell Cycle Checkpoints 
 
G1 Checkpoint - Cells in the G1 phase at the time of irradiation are deterred from 
entering the DNA replication phase (S phase) by the G1 (also called the G1/S) checkpoint (12, 
22, 27, 29).  In the absence of DNA damage, normal progression of cells from G1 to S phase is 
controlled by the cyclin E/CDK2 complex (23, 24, 27, 29).  To enable the G1/S transition, the 
cyclin E/CDK2 complex must be activated by Cdc25A, which if inactivated as a result of 
radiation induced DNA-damage events, prevents the cell from making the G1/S transition.  
Following radiation induced DNA damage, the sequence of events described below are believed 
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to lead to the activation of the G1 checkpoint, ultimately preventing the cell from proceeding to 
the S phase.  
The first step in the activation of the G1 checkpoint starts with detection of DNA 
damage.  Currently, many reports attribute the recognition of DNA double strand breaks (DSB) 
resulting from ionizing radiation to the ATM molecule (26, 29, 33, 34).  Bakkenist and Kastan 
have provided a model for DNA double strand break damage recognition by the ATM molecule 
(33).  They have demonstrated that, following ionizing radiation-induced DSB, changes in 
chromatin structure activates ATM, which exists in the nucleus in homodimeric form, causing it 
to dissociate from its homodimeric form to monomeric form by homodimer autophosphorylation 
on ser-1981 (33).  Each of the monomers then phosphorylate many downstream proteins 
involved in the cell cycle checkpoint activation such as Chk2 and p53 (reviewed in (29).  The 
activated ATM molecule then activates many downstream targets, that lead to two simultaneous 
pathways of events resulting in G1/S checkpoint arrest and maintenance (27, 29).  In one 
pathway, the DNA damage-activated ATM is thought to activate Chk2 by phosphorylation of 
Thr68 (35).  Activated Chk2 then phosphorylates Cdc25A phosphatase.  Phosphorylated Cdc25A 
is removed from the nucleus by ubiquitin-mediated proteolytic degradation (26, 29).  Decreased 
levels of Cdc25A in the nucleus lead to increased levels of phosphorylated cyclin E/CDK2 
complex.  Phosphorylated cyclin E/CDK2 is inactive and unable to phosphorylate Cdc45, which 
is necessary to set off
 
DNA synthesis (26, 29).  Immediately following the first pathway for G1/S 
checkpoint activation, is a second pathway for its maintenance (29).  While the first pathway is 
believed to be p53 independent, the second pathway is thought to be heavily dependent on the 
status of the p53 protein in the cell, because mutant cells lacking functional p53 have been found 
to have a defective G1/S checkpoint  (36).  Like the first pathway, the ATM has been associated 
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with initial recognition of radiation-induced DNA damage (37).  Upon recognition of the 
damage, the phosphorylated ATM activates Chk1 which, in turn, activates p53 by sequential 
phosphorylation  (38).  Phosphorylation of  p53 stabilizes it, thereby inhibiting it from nuclear 
export and degradation (27, 29). Consequently, active p53 accumulates in the nucleus and 
activates its target genes p21 (26-29).  Activated p21 binds to the Cdk2/cyclin E complex, thus 
preventing the S phase transition and maintaining the G1/S arrest (26, 27, 29). 
S Checkpoint - The G1 checkpoint prevents the cells irradiated in the G1 phase from 
entering the S phase with damaged DNA, but does not benefit the cells present in the S phase at 
the time of irradiation.  Evidence of the existence of the S phase checkpoint (also called intra-S 
checkpoint) came from observations that irradiated cells did not integrate radioactive precursors 
into newly synthesized DNA (39, 40).  Of the three checkpoints ( G1, G2, and S), mechanisms 
involved in the activation of the S checkpoint following irradiation are least understood.  Like 
the G1/S checkpoint, the S checkpoint also consists of two pathways (29) and is very similar to 
the first G1/S pathway described above, that is, the ATM-Chk2-Cdc25A-Cdk2 signaling cascade 
(27, 29).  Degradation of Cdc25A ultimately leads to inactivation of Cdk2/cyclin A/cyclin E 
complexes and a delay in DNA synthesis and replication (22, 41, 42).  The second pathway is 
less known and involves such molecular regulators as NBS1, Mre11, Rad50, and BRAC1 (43-
46).  Currently, the role of p53 and p21 proteins in S phase checkpoint is not fully elucidated and 
it is not clear if p53 is activated upon exposure to ionizing radiation (47, 48). 
 G2 Checkpoint - Cells entering the G2 phase with damaged DNA or those that are 
irradiated in the G2 phase are kept from entering the M phase with damaged DNA by the G2 
(also called the G2/M) checkpoint.  Currently, numerous reports have attributed a long G2 delay 
in cells with radioresistance to cell kill (49-51).  Conversely, defects in the G2 checkpoint have 
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been linked to elevated radiation sensitivity (49-51). By utilizing several human cell lines, there 
is mounting evidence suggesting the existence of two molecularly distinct G2/M checkpoints 
(33, 52).  The first is the traditional checkpoint that has been known for many years for cells 
irradiated at doses higher than 1 Gy, and is associated with accumulation of cells in G2 that were 
irradiated in the G1 and S phases (25, 53).  The second checkpoint appears to be activated in 
cells that are irradiated when they are already in the G2 phase of the cell cycle (52).  For higher 
doses (>1 Gy), activation of the classical G2/M check point has been demonstrated to be 
dependent on dose, while the second G2/M checkpoint is independent of dose. Studies at low 
doses of irradiation, albeit few, have demonstrated that cells irradiated with low doses exhibit 
activation of an early ATM dependent G2 checkpoint for cells irradiated in the G2 phase, while 
for cells irradiated in the S and G1 phases, reports  suggest the activation of a late ATM-
independent G2/M checkpoint (54, 55).  Irrespective of the phase at which the cells are 
irradiated, numerous studies have attributed the trigger of both types of G2 checkpoints to the 
recognition of DNA damage by the ATM protein (26-29, 33, 41, 55, 56).  Similar to the G1 an S 
checkpoints, the G2/M checkpoint also consists of two pathways, one for initiation and the other 
for maintenance of the checkpoint arrest.  Following DNA damage with ionizing radiation, the 
rapid ATM-Chk2-Cdc25A pathway is activated (22, 26, 34).  Once phosphorylated, Cdc25A 
phosphatase binds to 14-3-3 proteins, and it is extruded from the nucleus and sequestered in the 
cytoplasm where it is degraded by the ubiquitin proteosome pathway (29). Inactive Cdc25A 
phosphatase inhibits the activation of cyclin B/CDK1 complex, leading to G2/M block (29, 34). 
The maintenance of the G2/M checkpoint is accomplished by the p53/p21 pathway in a sequence 
similar to G1/S checkpoint maintenance (23, 29). As mentioned earlier, the function of these cell 
cycle checkpoints is to delay the progression through the cell cycle to allow for more time for 
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DNA to be repaired or to redirect unrepairable cells through a programmed cell death called 
apoptosis (27, 30, 51).  
 
1.3.2 Radiation-Induced Cell Death - Apoptosis and Necrosis 
 Irradiation of cells may not only activate DNA repair and cell cycle arrest, but can also 
lead to cell death through two principal mechanisms - necrosis and apoptosis. The decision about 
shunting the cell towards apoptosis or directing it along a DNA repair pathway is dependent on 
both cell type and the scale of the DNA damage (57). Necrosis is a passive cell death, often 
linked to damage so extensive that the metabolic machinery of the cell can no longer function 
well enough to undergo either repair or programmed death. Cells undergoing necrotic death 
show early loss of membrane permeability, dilation of cytoplasmic vesicles, swelling, lysis and 
elicitation of an inflammatory response
 
that can potentially damage surrounding tissue (58).  On 
the other hand, apoptosis, commonly described as a programmed cell death, is a highly regulated 
program initiated by the cell.  It is characterized by morphological changes such as chromatin 
condensation, cell shrinkage, nuclear and cytoplasmic blebbing and formation of membrane 
bound apoptotic bodies,
 
and it requires energy in the form of ATP.  In apoptotic cells, 
degradation of the DNA has been observed to come before loss of membrane integrity (58). 
 Radiation-induced cell death via necrosis is well documented, and, currently, there is 
mounting evidence that suggests exposure of cells to ionizing radiation generates reactive 
oxygen species (ROS) that can initiate oxidation of membrane lipids, thereby setting off 
apoptosis (59, 60).  γ-irradiation of normal human lymphoblasts with 20 Gy was found to 
increase apoptosis significantly above those of unirradiated controls (60), while x-irradiated 
U937 human monoblastic leukemia cells generated 80% increase in ceramide (a marker of 
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apoptosis) levels (61). Rat-1 Myc-ER fibroblastic cells exposed to 10 Gy also had 80% more 
ceramide levels compared to the control (62).  
 
1.3.3 MAPK Signal Transduction Pathways Activated by Radiation 
Several reports written in the last decade indicate that exposure to ionizing radiation not 
only leads to the classically held paradigm of DNA damage and subsequent cell cycle arrest 
and/or death, but also can stimulate pathways that trigger cell proliferation (3, 63-66).  For 
example, studies have demonstrated that exposure of cells to ionizing radiation can activate 
cytokine receptors such as epidermal growth factor receptors (EGFR) and tumor necrosis factor 
receptors (TNFR) on the cell membrane, and can set off the mitogen activated protein kinase 
pathways (MAPKs) similar to those activated by growth factors and other external cellular 
stresses (3, 63-66).
  
In human cells, there are three families of fairly understood MAPK 
pathways. These include (1) the ras-MAPK (also known as the extracellular signal-regulated 
kinase 1 and 2 or ERK1/2) signal transduction pathway which transmits extracellular signals 
from the receptor tyrosine kinase and the heterotrimeric G-protein linked receptor which induce 
cell proliferation and differentiation, (2) the c-jun NH2-terminal kinase (JNK) pathway that is 
also activated by extracellular stresses like heat, high osmolarity, UV irradiation, and pro-
inflammatory cytokines, and (3) the p38 MAPK pathway that is traditionally activated by 
osmotic stress, heat shock, tumor necrosis factor α (TNF) and interleukin 1(IL-1) (66, 67).  All 
three of these pathways are, in general, organized at three levels consisting of a MAPK, a MAPK 
kinase activator (MAPK kinase, MEK or MKK), and a MAPK kinase kinase ( MEK kinase or 
MAPKKK).  Signals are transmitted by phosphorylation from upstream MAPKKKs to 
downstream MAPKs. 
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Figure 1.5:  Organization of MAPK Pathways 
 
 The Ras/ERK1/2 signal transduction pathway - It is now fairly understood that one of the 
defense mechanisms cells utilize to cope with  radiation insult is to enhance proliferation in the 
surviving fraction of cells (68) by triggering signal transduction pathways such as the 
Ras/ERK1/2 that lead to activation of genes involved in cellular proliferation and prevention of 
apoptosis.  Indeed, studies indicate that exposure of cells to ionizing radiation can activate the 
epidermal growth factors receptor (EGFR, also called ERBB1 and HER1) in several normal and 
carcinoma cells, leading to increased proliferation (3, 69, 70).  For instance, activation of the 
epidermal growth factor in MCF-7, A431 and MDA-MB-231 cancer cells was observed at a dose 
of about 0.5 Gy (3, 71), and some scientists have argued that the reason we sometimes have poor 
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prognosis in treating cancers in vivo with a radiotherapeutic protocol is because the ionizing 
radiation may be activating the epidermal growth factor receptors that cause increased tumor 
growth. 
The MAPK, ERK1 protein was described for the first time in 1986 as a 42-kDa protein 
that was stimulated after insulin exposure (72). Soon after its discovery, another closely related 
protein of 44-kDa was also revealed and demonstrated to share the same function as the 42-kDa 
protein discovered earlier.  These two proteins are closely related in function, and they are 
designated as ERK1/2.  Many growth factors and mitogens have been demonstrated to activate 
ERK1/2, and, for this reason, this protein has popularly been referred to as mitogen-activated 
protein kinase or MAPK.  Studies have shown that the MAPKs are regulated by another protein 
kinase MKK1/2 (also designated MAPKK, or MEK1/2) (67, 73).  The MKK1/2 are, in turn, 
activated by the kinase activity of a family of serine-threonine protein kinases Raf1 (73, 74).  
Additionally, it has been suggested that the Raf1 proto-oncogenes can inhibit apoptosis signaling 
kinase 1 (ASK1).  Briefly, the mechanism by which ionizing radiation appears to be acting is 
through the initiation of a phosphorylation cascade that starts with activation of plasma 
membrane growth factor receptors , subsequent activation of Ras (through the exchange of GDP 
for GTP) which leads to Raf1-MKK1/2-ERK1/2 activation as presented in Figure 1.6 below.  
Phosphorylated ERK1/2 then translocates to the nucleus where it activates several substrates 
such as c-myc, c-fos, c-jun, Rsk, SOS, Elk-1,and STATS (75).  C-fos, c-myc and c-jun proteins 
and mRNA are stabilized by activated ERK1/2, which, in turn, play a key role in cell 
proliferation, differentiation, and oncogenic transformation (76).  
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Figure 1.6:  The ERK Signal Transduction Pathway 
 
 
At doses of radiation greater than 1 Gy, several reports have demonstrated activation of 
the ERK pathway by phosphorylation of the EGFR receptors and, subsequently, setting off the 
whole ERK1/2 signaling transduction pathway (3, 77, 78).  Carter et al showed that 1 Gy of 
radiation can cause more activation of ERK1/2 than 6 Gy of radiation (79).  Several studies by 
Schmidt-Ullrich et al have shown that activation of the EGF receptors in A431 squamous 
carcinoma cells and MDA-MB-231 differ for low and high radiation doses (3, 78).  Currently, 
studies on activation of the ERK1/2 pathway at low doses of radiation are very limited.  Suzuki 
et al demonstrated that doses between 2 cGy and 5 cGy enhanced proliferation in normal human 
diploid cells and phosphorylated ERK1/2 as efficiently as 6 Gy of dose (19).  Kim et at 
demonstrated that a dose of 5 cGy stimulated proliferation through activation of transient 
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ERK1/2 (20).  However, the mechanism of low dose radiation-induced proliferation is currently 
not well understood, and more studies are needed to elucidate this phenomenon. 
The c-JUN NH2-terminal kinase pathway (JNK) - Another MAPK pathway that can be 
activated when cells are exposed to ionizing radiation is the c-JUN NH2-terminal kinase.  The c-
JUN NH2-terminal kinase pathway was discovered in the 1990s (80) and was initially thought to 
be initiated only by environmental stress.  For this reason, it is also called stress activated protein 
kinase (SAPK) (81).  However, it is now known that the c-JUN NH2-terminal kinase pathway 
can also be activated by UV radiation, ionizing radiation, cytotoxic drugs, and reactive oxygen 
species such as H2O2  (82).  Unfortunately, at present, it is not clearly known how ionizing 
radiation initiates the c-JUN NH2-terminal kinase phosphorelay cascade.  However, there are two 
proposals on the mechanism of activation.  The first implicates the Ras proto- oncogene, while 
the second proposes activation through either the P13K or the protein kinase C or both (80, 83) 
Activation of the JNK pathway follows a parallel route only slightly different from the 
Ras-MAPK pathway (see Figure 1.7 below).  However, in the JNK pathway, the GTP- binding 
Rho families of proteins play a role similar to the Ras to trigger the JNK pathway.  Examples of 
Rho family proteins involved are the Rac1 and cdc42 (84).  The MAPKKK of the SAPK/JNK 
signal pathway consist of the kinases MKKK1-4, TAK-1 and Tpl-2.  Activated MKKKs activate 
the MKKs which, in turn, activate the MAPKs JNK1 and JNK2.  Protein kinases that serve as 
MKKs in the SAPK/JNK pathway include the MKK-7 and the MKK-4. 
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Figure 1.7:  The JNK Signal Transduction Pathway 
 
JNK1/4 has been demonstrated to play a central regulatory role in apoptosis (85) .  
Studies have shown that the binding of p53 protein to JNK leads to ubiquitin-mediated 
degradation of p53 (85-87).  The JNK1/2 are capable of phosphorylating the NH2-terminal sites 
in c-Jun and c-Myc, and, ultimately, inducing cell apoptosis (61, 88).  Phosphorylated JNK has 
been shown to target both pro-and anti-apoptotic members of the Bcl-2 familly.  Several studies 
have demonstrated inhibition of anti-apoptotic proteins Bcl-2 and Bcl-xl by phosphorylated JNK 
(89), while other studies have shown JNK is involved in the degradation of caspase 8 inhibitor 
(90). 
Currently, most studies that link the activation of the JNK pathway to radiation have been 
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exploring JNK pathway activation following low dose radiation are far fewer in number.  
However, recent studies in several cell lines have shown that low doses of radiation can cause 
disproportionately higher cell death than would have been predicted by extrapolation back from 
the reports using exposure of cells to high doses of radiation (17, 55, 56, 91-96), and there is 
speculation that this observed radio-hypersensitivity in the low dose region may be linked, at 
least in part, to apoptosis (96, 97). 
The p38 MAPK pathway - Signalling through the p38 pathway has been shown to be 
similar to both JNK and Ras pathways (see Figure 1.8 below).  The p38 MAPK pathway is 
activated through Rho families of GTPases, which are activated by phosphorylated receptors 
following irradiation. Activation of p38 by ionizing radiation at high doses has yielded 
unpredictable results, ranging from strong (98) to weak (99) to no activation (100) of the 
pathway.  p38 has been shown to be activated by other factors as well such as environmental 
stress, inflammatory cytokines, insulin and growth factors (101, 102).  The PAK family of 
kinases plays the role of the MAPKKK (103), while the MAPKK kinases consist of the MKK3 
and the MKK6 (104). The four p38 MAPK so far known are p38α, p38β, p38γ and p38δ (105).  
P38 has been shown to phosphorylate and, subsequently, activate various substrates including 
ATF (activating transcription factors), GADD  (growth arrest DNA damage 153), CREB, and 
SRF (106, 107).  Kim et al demonstrated that 5 cGy of ionizing radiation enhanced proliferation 
through the activation of ERK1/2 and p38 in normal human lung fibroblasts (20).  Of interest, 
the p38 MAPK pathway has been demonstrated to promote both cell death as well as cell 
survival (108, 109), but, currently, the mechanisms of low dose radiation hyper-
radiosensitivity/hyper-proliferation still remain unclear. 
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                            Figure 1.8:  The p38 Signal Transduction Pathway 
 
1.3.4 NF-κB Transduction Pathways Activated by Radiation 
 NF-κB is a major transcription factor involved in the regulation of genes that are involved 
in response to cellular stress (110-114).  In unstimulated cells, NF-κB resides in the cytoplasm 
complexed to its inhibitory protein IκB (Inhibitor of κB) (114, 115).  When activated by either 
internal or external stress (i.e. radiation), NF-κB is released from its inhibitor IκB, translocates to 
the nucleus where it binds to DNA and upregulates transcription of stress response genes (116).  
Several studies have demonstrated the potential of radiation to activate NF-κB (113, 117), with 
three main mechanisms of action being described (see Figure 1.9).  First is activation through the 
protein kinases ATM and DNA-PK that are involved in sensing damaged DNA (117-119).  On 
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to phosphorylation of the IκB proteins, thereby permitting release of the NF-κB from its inhibitor 
and subsequent translocation to the nucleus.  A second mechanism being reported is that 
radiation-induced ROS directly stimulate the IKK (IκB kinase) complex that, in turn, 
phosphorylates IκB, releasing the NF-κB from its tether in the cytoplasm and allowing it to 
translocate to the nucleus (120).  Finally, it has been demonstrated that radiation-induced ROS 
can activate the TNFR (tumor necrosis factor receptors) family of membrane receptors.  Once 
activated, the TNFR engage the NF-κB inducing kinase (121) to phosphorylate the IKK, 
initiating the cascade that results in NF-κB relocating to the nucleus. 
 
Figure 1.9:  NF-kB Activation by Ionizing Radiation 
Several studies have reported radiation-induced NF-κB activation, but results vary 
greatly.  In most of these studies, doses required for maximal activation of NF-κB are dependent 
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on cell type and experimental conditions. For example, U1-Mel human melanoma cells exposed 
to IR displayed a steady increase in activation of NF-κB from 0 to 4.5 Gy, after which activation 
fell gradually with increasing dose (122).  However, in the KG-human myeloid cell line, NF-κB 
was increasingly activated by ionizing radiation from 2 Gy upward, peaking at doses between 5 
to 20 Gy (123).  Finally, in human EBV-transformed 244B human lymphoblastoid cells, 
activation of NF-κB was observed between 0.25 -2 Gy with a maximum at 0.5 Gy (124).  
 
1.4 LOW DOSE RADIATION PHENOMENA 
 As stated previously, scientists are documenting a host of unexpected and seemingly 
contradictory responses following exposure to low doses of radiation. For example, observations 
of bystander effects (13-15), low dose hyper-radiosensensitivity (17, 125, 126)  and even hyper-
proliferation (19-21)
 
have increasingly been reported in the literature.  In the sections that follow, 
some of these responses will be discussed. 
 
1.4.1 Low Dose Hyper-Radiosensensitivity 
 In the last decade, several in vitro studies have demonstrated that cell survival  curves at 
low doses (below 1 Gy) deviate from the standard linear quadratic cell survival curve 
extrapolated from high doses (17, 54, 92, 93, 126).  For many cell lines, this deviation is 
evidenced as increased hyper-radiosensitivity (greater than predicted cell death) in the dose range 
below 50 cGy. The exact mechanisms and pathways responsible for the hyper-radiosensensitivity 
are not completely understood, although several explanations have been proposed to explain the 
shape of the curve.  One currently popular explanation given for the hyper-radiosensensitivity 
curve is that cells need to accumulate some minimum damage before DNA repair mechanisms 
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are turned on (56).  If DNA damage is below this minimum amount, there is no upregulation of 
repair pathways and the damage remains within the cell and may lead to eventual mitotic failure 
and death.  In support of this damage threshold theory, it was observed that cells pre-treated with 
very low concentrations of hydrogen peroxide before irradiation did not display the hyper-
radiosensensitivity seen in irradiated-only cells (127), because the DNA damage from hydrogen 
peroxide added on to the DNA damage from the radiation surpassed the damage threshold 
required for the activation of DNA repair pathways.  Furthermore, hyper-radiosensensitivity was 
not observed in V79 Chinese hamster cells that were pre-irradiated with 20 cGy of x-rays (127).  
Nevertheless, not all researchers currently support the DNA damage threshold concept.  Some 
have argued that most DNA repair data from low dose radiation studies have been based on 
indirect estimates of DNA damage (measuring γ-H2AX foci) and not direct measurement of 
DNA double strand breaks (128). 
 It is also not clear at present how radiation-induced cell cycle arrest is related to the 
hyper-radiosensitivity responses observed.  However, several researchers have shown that those 
cells in the G2 phase of the cell cycle at the time of irradiation contribute significantly to hyper-
radiosensitivity (54, 55, 125, 129).  For example, Kruegar and colleagues have shown that cells 
in the G2 phase play an important role in the hyper-radiosensensitivity phenomenon, because 
enrichment of V79 Chinese hamster with G1 and S phases did not display a hyper-
radiosensensitivity phenomenon (55), but a G2 phase-enriched cell population showed a 
significant hyper-radiosensitivity phenomenon (125). 
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1.4.2 Low Dose Radiation-Induced Hyper-Proliferation 
Despite the prevalence of low dose hyper-radiosensensitivity in many cell types, other 
studies have shown that there exist cell lines that display low dose hyper-proliferation (19, 20, 
130).  The mechanism underlying low dose hyper-proliferation is yet to be completely 
elucidated, but is believed to involve activation of growth factors.  Specifically, in addition to 
DNA damage, radiation-induced membrane-associated changes include activation of major 
growth regulators such as epidermal growth factor receptors (EGFR), tumor necrosis factor 
receptors (TNFR) and  tyrosine kinase receptors (3, 61, 69, 78).  For example, activation of the 
EGFR in the plasma membrane has been associated with stimulation of the MAPK pathways 
(78, 79) which, as described previously, are important mediators of enhanced cell 
proliferation/survival.  Studies are still somewhat limited, but hyper-proliferation of γ-irradiated 
Chinese hamster fibroblasts and Raji lymphoma cells has been reported to be enhanced at doses 
between 2 and 10 cGy (130).  Additionally, irradiation at doses between 2 and 5 cGy has been 
documented to cause hyper-proliferation in normal human HE49 cells (19).  Finally, exposure to 
50 cGy has been reported to stimulate induction of cell proliferation in mouse hematopoietic 
cells (21), and irradiation at 5 cGy has been shown to enhance cell proliferation via transient 
ERK1/2 and p38 activation in normal human lung fibroblasts (20). 
 
1.5 HYPOTHESIS AND SPECIFIC AIMS 
 The biological effects of radiation are governed by many factors, including the cell type 
being irradiated.  Previously, within our laboratory, it was observed that the human melanoma 
A375 cell line appeared to demonstrate an interval of increased radioresistance following very 
low doses of radiation.  This was in sharp contrast to much of the reported literature which 
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suggests the majority of cell lines irradiated at these very low doses demonstrate a hyper-
radiosensensitivity response, among which is the human prostate carcinoma PC3 line.  It is the 
hypothesis of this proposal that the contradictory responses of the A375 and PC3 cell lines 
following very low dose radiation exposures is due to differential regulation of mediators 
controlling two critical signaling pathways within the cell – the pathways involved in cell cycle 
progression and cellular proliferation (mitogen activated protein kinase or MAPK pathway and 
the nuclear factor kappa B or NF-κB pathway).  The principal objective of this research is to 
better characterize the cellular response to low dose radiation in these two cell lines and to 
ascertain the role these molecular pathways play in bringing about this cellular response.  To 
accomplish this, the following specific aims were developed: 
 
1.5.1  Specific Aim 1 
 To compare cell survival responses in A375 human melanoma cells and PC3 human 
prostate cancer cells at doses of radiation ranging from 0 to 100 cGy. 
 
1.5.2 Specific Aim 2 
 The second aim of these studies was to investigate the temporal kinetics and magnitude 
of cell cycle arrest that occurs following low dose radiation exposure in the A375 and PC3 cell 
lines over a series of doses ranging from 0 to100 cGy.  
 
1.5.3 Specific Aim 3 
The third aim of these studies was to investigate the effect of low doses of radiation on 
the expression of cell cycle regulator proteins in an effort to correlate the temporal changes in 
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cell cycle distribution observed in Specific Aim 2 with the downregulation of specific cyclin 
levels within the cell. 
 
1.5.4 Specific Aim 4 
 The fourth aim of these studies was to ascertain whether signaling through the MAPK, 
and NF-κB proliferative pathways is being altered as a function of cellular exposure to low dose 
radiation (0-100 cGy). 
 
  
 
CHAPTER 2:  EXPERIMENTAL DESIGN AND METHODS 
2.1 EXPERIMENTAL MODEL  
The principal objective of this research was to better characterize the molecular pathways 
involved in the cellular responses to very low doses of ionizing radiation. To accomplish this, we 
have chose two cell models – the A375 human melanoma cell line and the PC3 prostate 
carcinoma cell line. The reason these models were chosen is three fold.  First, these cell lines 
were selected because they represent the opposite ends of the spectrum with regard to radiation 
sensitivity.  For example, in classical dose-response survival studies (1 Gy and greater), the 
A375 cells have been shown to be moderately resistant to radiation, while the PC3 cells have 
been shown to be relatively sensitive to radiation. 
Secondly, as stated above (Hypothesis and Specific Aims), preliminary studies within our 
laboratory observed that the human melanoma A375 cell line appeared to demonstrate an 
interval of hyper-radioresistance following very low doses of radiation which was in sharp 
contrast to reported literature that argued that PC3 cells display very low dose hyper-
radiosensensitivity (129, 131). 
Finally, because numerous other studies have used these two cell lines, a strong data base 
exists on these cell lines upon which we can obtain relevant information pertaining to cellular 
response, experimental design and maintenance. Specifically, A375 cells are characterized by 
having a wild type p53 and a mutated tumor suppressor gene BRCA1. They also have been 
shown to possess aberrant caspase 3 activity and a strong tendency for ATM phosphorylation 
after irradiation, by the association of the ATM with the RAD50/MRE11/Nibrin complex 
involved in double-strand break repair through both homologous recombination and 
nonhomologous end-joining  (132).  On the other hand, the radiosensitive PC3 prostate 
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carcinoma cells possess a mutated p53, have strong metastatic ability and exhibit some caspase 3 
activity. 
 
2.2 EXPERIMENTAL DESIGN  
2.2.1 Experimental Design for Specific Aim 1:  Comparison of cell survival responses in A375 
human melanoma cells and PC3 human prostate cancer cells at low doses of radiation.  
 One of the goals of these studies was to characterize the survival response following low 
dose radiation in two experimental cell lines – the A375 human melanoma cell line and the PC3 
prostate carcinoma cell line.    Cell survival was assessed using a standard clonogenic assay over 
a series of low dose radiation exposures (0, 2, 5, 10, 25, 50 and 100 cGy).  Briefly, the 
clonogenic assay or colony formation assay is an in vitro cell survival assay based on the ability 
of a single cell to grow into a colony (defined to consist of at least 50 cells), and essentially tests 
for a cell‟s reproductive integrity (ability to undergo “unlimited” division).  The clonogenic 
assay has been chosen for these studies, because it has long been accepted as the “gold standard” 
for determining actual cell survival following irradiation.  It has been argued that many of the 
more rapid cell viability assays provide an incomplete assessment of cell killing, since they may 
not be able to distinguish growth inhibition with actual death, and they may assess only events 
that have occurred up to the time of the assay.  
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2.2.2 Experimental Design for Specific Aim 2:  Investigation of the effect of low dose radiation 
exposure on cell cycle progression in A375 human melanoma cells and PC3 human prostate 
cancer cells. 
The importance of ionizing radiation as a disruptor of cell cycle progression is well 
documented, and, for this reason alone, the cell cycle pathway must be considered in any 
investigation that includes radiation.  Indeed, it has long been held that one of the cell‟s major 
defenses against radiation damage is to halt progression through the cell cycle (25)
 
for a
 
sufficient amount of time to affect repair of
 
DNA damage, and, in both asynchronous and 
synchronous cell populations, a G2/M cell cycle arrest has been observed in a large spectrum of 
cell types over a broad range of radiation doses (50).
  
Several of these studies have reported that 
radioresistant cells tend to have a more marked G2/M arrest than radiosensitive cell lines have 
(133), and Marples et al  have postulated that failure to arrest in G2 phase following low dose 
radiation may be responsible for the low dose hyper-radiosensensitivity observed in some cell 
lines (125).  The second aim of this proposal, therefore, is to investigate the kinetics and 
magnitude of cell cycle arrest that occurs following low dose radiation exposures (0, 2, 5, 10, 25, 
50 and 100 cGy) in the A375 and PC3 cell lines using flow cytometric analysis of cell cycle 
distributions over a 24 hour interval following irradiation. 
Briefly, the principle underlying the flow cytometric technique is as follows.  The nuclear 
DNA content of a cell can be quantitatively measured by flow cytometry using a procedure that 
involves binding a fluorescent dye to the DNA of a suspension of permeabilized single cells.  
The assumption is that the stained cellular material has incorporated an amount of dye 
proportional to the amount of DNA present. The stained material is then measured in the flow 
cytometer, and the emitted fluorescent signal yields an electronic pulse with a height 
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proportional to the total fluorescence emission from the sample. Thereafter, such fluorescence 
data are considered a measurement of the cellular DNA content, and distribution of cells in the 
into G0/G1, S and G2/M cell cycle phases can be obtained on the basis of their differing DNA 
content using software analysis programs such as ModFit (see schematic below from our 
laboratory experiments). 
 
Figure 2.1.  Flow Cytometric Histogram of A375 Cell Cycle Distribution  
with ModFit Analysis Data Included 
 
2.2.3 Experimental Design for Specific Aim 3:  Investigation of the effect of low dose radiation 
exposure on the expression of cell cycle regulator proteins in A375 human melanoma cells and 
PC3 human prostate cancer cells 
The third aim of this proposal is to investigate the effect of low doses of radiation on the 
expression of cell cycle regulator proteins.  In normal cells, progression through the cell cycle is 
regulated at various checkpoints by a group of proteins known as cyclins, their corresponding 
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cyclin dependent kinases (CDKs), and their cyclin kinase inhibitors (CKIs).  Reductions in the 
levels of cyclins or CDKs, or increases in the levels of CKIs, therefore, will effectively decrease 
the probability of transiting through these checkpoints, and cell cycle arrest will occur. For 
example, because progression through the G2 phase is moderated by cyclin B/CDK1, a complex 
that induces mitosis by phosphorylating and activating enzymes regulating chromatin 
condensation, nuclear membrane break down and microtubule reorganization, decreases in the 
levels of cyclin B can reduce the concentration of this complex, increasing the likelihood of cell 
cycle arrest in G2/M.  Hence, in an effort to correlate the temporal changes in cell cycle 
distribution observed in Specific Aim 2 with the alterations of specific cyclin levels within the 
cell, this aim proposes to monitor the expression of cyclins involved in cell cycle phases 
observed to demonstrate an arrest as analyzed by the flow cytometric studies performed in 
Specific Aim 2.  Expression levels will be assessed using Western blot analysis of cell lysates 
derived from cells exposed to 0, 2, 5, 10, 25, 50, and 100 cGy over a 24 hour interval following 
irradiation.  Briefly, the Western blot procedure is a widely used analytical technique which is 
used to detect specific proteins within a cellular extract or tissue homogenate.  It uses gel 
electrophoresis to separate denatured proteins according to their polypeptide length.  The 
proteins are then transferred to a PVDF membrane where they are detected by probing with 
antibodies specific to the target protein. 
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2.2.4 Experimental Design for Specific Aim 4:  Analysis of the phosphorylation status of the 
members of the MAPK kinases and Nf-κB pathways following low dose radiation in the A375 
human melanoma and PC3 human prostate carcinoma cell lines. 
 Ionizing radiation can activate growth factor receptors on the cell membrane, which, in 
turn, can trigger upregulation of proliferative pathways such as the MAPK and NF-κB pathways.  
The fourth aim of this proposal is to ascertain whether signaling through these proliferative 
pathways is being upregulated as a function of cellular exposure to low doses of radiation (0, 2, 
5, 10, 25, 50 and 100 cGy).  These studies were accomplished by measuring the levels of 
phosphorylated ERK1/2, JNK1/2, p38 and NF-κB within these pathways.  The rationale for 
selecting these proteins is that they represent key indices of their respective pathways.  
Expression of these molecules will be determined for cell populations exposed to 0, 2, 5, 10, 25, 
50, and 100 cGy over a 24 hour interval following irradiation using enzyme linked 
immunosorbent assays (ELISA).  Briefly, the principle underlying this assay is as follows.  
Enzyme-linked immunosorbent assay (ELISA) is a biochemical technique used to detect the 
presence of an antibody or an antigen in a sample. In simple terms, an unknown amount of 
antigen is affixed to a surface, and then a specific antibody is applied over the surface so that it 
can bind to the antigen. This antibody is linked to an enzyme, and, in the final step, a substance 
containing the enzyme's substrate is added.  The ensuing reaction produces a detectable color 
change in the substrate which can be analyzed spectrophotometrically to measure how much 
antigen is present. 
Ionizing radiation can activate growth factor receptors on the cell membrane, which, in 
turn, can trigger upregulation of proliferative pathways such as the MAPK and NF-κB pathways.  
The fourth aim of this proposal is to ascertain whether signaling through these proliferative 
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pathways is being upregulated as a function of cellular exposure to low doses of radiation (0, 2, 
5, 10, 25, 50 and 100 cGy).  These studies were accomplished by measuring the levels of 
phosphorylated ERK1/2, JNK1/2, p38 and NF-κB within these pathways.   
 
2.3 MATERIALS AND METHODS 
2.3.1 Antibodies and Reagents 
Phospho-ERK1/2, phospho-JNK1/2, phospho-p38, phospho-NF-κB and cyclin B1 
antibodies were purchased from Cell Signaling Technology (Danvers, MA).  Fetal calf serum 
was purchased from HyClone Laboratories (Logan, Utah).  Iscove‟s Modified Dulbecco‟s 
Media, penicillin/streptomycin, and Triton X-100 were purchased from Sigma Aldrich (St. 
Louis, Missouri).  All secondary antibodies (anti-rabbit HRP-conjugated and goat anti-rabbit 
HRP-conjugated, anti.mouse AP-linked) were purchased from Cell Signaling Technology 
(Danvers, MA). The chromogenic substrate for horseradish peroxidase in ELISA experiments 
was TMB (3,3´,5,5´-tetramentylbenzidine) with brand name 1-Step™ Ultra TMB-ELISA was 
purchased from Thermo Scientific (Pierce, Rockford, IL).  For Western blots, the chromogenic 
substrate was nitro blue tetrazolium/5-bromo-4-chloro-3-indolyl-phosphate from Promega 
(Madison, WI). 
 
2.3.2  Tumor Cell Lines and Culture Conditions  
The A375 human melanoma  and PC3 human prostate cancer cell lines were purchased 
from American Type Culture Collection (Bethesda, MD), and were routinely maintained under 
sterile conditions in Iscove‟s Modified Dulbecco‟s Media (Sigma Aldrich, St. Louis Missouri) 
supplemented with 10% fetal calf serum (HyClone Laboratories, Logan, Utah) by incubating at 
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37
0
C, 5% CO2/95% air.  Cell cultures were passaged weekly by trypsinization and replating at a 
density of 2x10
3
 and 5x10
3
 cell/cm
2
 for A375 and PC3 cells, respectively. 
 
 
2.3.3 Ionizing Radiation  
A375 and PC3 cells were exposed to varying doses of x-rays  from 0-100 cGy using a 
Siemens Stabilipan x-ray generator housed in a lead-lined 7 ft by 14 ft room within the Division 
of Radiation Biology.  The beam of radiation was delivered using 250 kVp x-rays, 15mA and 
2mm Cu filtration.  X-Ray dose output was calibrated weekly using a Victoreen ionization 
chamber to insure accuracy of dose delivery.  The irradiation setup is presented in Figure 2.2. 
 
Figure 2.2:  Schematic Diagram of Irradiation Setup 
 
2.3.4 Clonogenic Cell Survival Assay  
The fraction of cells that survive after irradiation was assessed by the clonogenic survival 
assay which measures the fraction of cells that continue to reproduce for at least five times after 
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irradiation.  For this assay, cells were grown to 70-80% confluency, and harvested by 
tripsinization, counted on a hemocytometer and diluted to 1x10
4
 cells/ml of growth media.  Cells 
were then seeded in 35 mm petri dishes with 2 ml of growth medium at appropriate dilutions to 
yield 40-60 colonies per dish.  Quadruplicate dishes were used for each experimental data point. 
Cells were allowed to settle and attach for 8 hours before being exposed to irradiation at various 
doses.  Dishes were then incubated at 37
o
C in 5% CO2 in a humidified incubator to form colonies 
for either 9 days (A375) or 14 days (PC3).  Colonies were washed with PBS, air dried, stained 
for 10 minutes with 0.5% crystal violet in methanol, and washed with running tap water to 
remove nonspecific staining.  Colonies (>50 cells) were enumerated under a Fisher Stereomaster 
II 10X stereoscopic microscope. For each quadruplet set of dishes, the mean, standard deviation 
and standard error was calculated. The cell survival fraction (SF) was calculated from the 
formulae:  
   
                            
                                
 
2.3.5 Flow Cytometric Analysis  
Cellular DNA content was determined at different intervals (0-24 hours) after exposure of 
the A375 and PC3 cells to 0-100 cGy of x-ray radiation.  To accomplish this, either the A375 or 
the PC3 cells were grown 70-80% confluency in either 25-cm
2 
or 75-cm
2 
at a density of 2x10
3
 
cells per cm
2 
(A375) or 4x10
3
 cells per cm
2
 (PC3). On the day of irradiation, fresh pre-warmed 
growth media was replaced in each flask. The cells were then irradiated in triplicates at doses of 
0 2, 5,10, 25, 50 and 100 cGy.  For each dose, at various time points (1, 2, 4, 6, 8, 12, and 24 
hours) following radiation, the cells were harvested by trypsinization. Harvested cells were 
centrifuged, and the pellet washed twice in 2ml of PBS, and fixed by resuspending 1x10
6
 
cells/ml in  ice cold 70% ethanol and stored at -20
0
C until the day of flow cytometric analysis.  
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Prior to analysis, cells were treated with 50µg/ml  RNase A (made up in PBS) for 30 minutes at 
37
o
C and, then, incubated with 20µg/ml of propidium iodide (Sigma-Aldrich, St Loius MO)  
suspended in PBS, 2% FBS and 0.01% NaN3 for 20 minutes at room temperature.  Stained nuclei 
were analyzed for DNA-PI fluorescence with a FACScan (Becton Dickinson Immunocytometry 
Systems, San Jose, CA, USA), and resulting DNA distributions were analyzed using ModFit 
software (ModFit for Mac Version 3, Verity software House Inc, Topsham, USA) to determine 
the proportion of cells in G0/G1, S, and G2/M.  At least 2x10
4
 events were analyzed per sample. 
 
2.3.6 Cell-Based ELISA 
Protein levels of phosphorylated ERK1/2, JNK1/2, p38 and NF-κB were determined 
using 96-well polystyrene microtiter plates. Optimal cell numbers to be seeded per well were 
determined by plating different cell densities and plotting a calibration curve.  It was found that 
cell densities between 4x10
4
 and 6x10
4
 per well gave the most reliable response at 540nm.  Cells 
were grown to 70-80% confluency, harvested by trypsinization, and, seeded in 96-well plates 
(4x10
4
 cells per well).  Plates were then returned to the incubator for 16 hours before being x-
irradiated with doses ranging from 0-100 cGy.  Following irradiation, cells were incubated for 5 
hours and, then, fixed in 4% formaldehyde for 20 minutes at room temperature.  The cells were 
washed in PBS containing 0.1% Triton X-100 (Sigma, St. Louis, MO; hereafter referred to as 
Wash Buffer) and quenched in 100μl of Wash Buffer containing 1% H2O2 and 0.1% sodium 
azide for 20 min at room temperature to inactivate endogenous peroxidase activity.  After 
additional washing steps, cells were blocked in Wash Buffer containing 5% goat serum for 1 
hour, and incubated overnight in various dilutions of primary antibody as per the manufacturer‟s 
instructions (Cell Signaling, Danvers, MA).  Cells were then washed three times in wash buffer, 
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then incubated with secondary antibody (HRP-conjugated goat anti-rabbit antibody; dilution 
1:1000, Cell Signaling, Danvers, MA) in Wash Buffer with 5% bovine serum albumin (BSA) for 
1 hour at room temperature, followed by incubation with 100 μl of 1-step ULTRA TMB ELISA 
(TMB; Pierce, Rockford, IL) for 15-20 minutes at room temperature before addition of 50μl of 
2M H2SO4.  The absorbance at 450nm and 620nm was measured with a microplate reader. After 
further washing, the cells were dried and stained with 100μl of crystal violet for 30 minutes prior 
to adding 1% SDS for 1 hr, and taking the absorbance at 540nm.  The relative activation of the 
phosphorylated proteins was calculated by the formula below: 
 
                    
                                       
                   
 
 
2.3.7 Western Blotting 
To obtain cell lysates for Western blot analysis, A375 and PC3 cells were grown to 60-
70% confluency, refed with fresh IMDM growth medium, irradiated at the appropriate dose (0, 
2, 5, 10, 25, 50 & 100 cGy) and incubated for various time points ranging from 0-24 hrs prior to 
harvesting by trypsinization.  Harvested cells were then pelleted at 400g for ten minutes, washed 
and resuspended in ice cold lysis buffer (25mM Tris , 50mM NaCl, 2% IGEPAL, 0.2% SDS and  
0.5% deoxycholic acid, 1mM PMSF, 50ug/ml aprotinin, 24ug/ml leupeptin and 0.5mM sodium 
orthovanadate at a pH of 7.4), and incubated for 30 minutes on ice with vortexing performed 
every 5 minutes. The cell extracts were then centrifuged (20 minutes, 10,000g, 4
o
C), 
supernatants (lysates) aliquoted into multiple tubes and stored at -20
o
C until analysis. Protein 
content for the lysates was determined using Bradford analysis. For Western blotting, lysates 
were mixed 1:1 with 2x sample loading buffer (100mM Tris-HCI pH 6.8, 4% SDS, 0.2% 
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bromophenol blue, 20% glycerol, 200mM dithiothreitol) and samples (20µg) were resolved on 
10% SDS-polyacrylamide gels at 150V constant voltage in standard buffers (25mM Tris with 
200mM glycine and 0.1% SDS).  Pre-stained molecular weight markers were run on gels to 
provide a visible QC on protein transfer along with molecular weight standards (Santa Cruz, 
CA).  After electrophoresis, gels were rinsed in ice-cold transfer buffer (24.8 mM Tris base, 192 
mM glycine, 10% methanol, pH 8.3) and proteins transferred to prepared polyvinylidene 
difluoride (PVDF) membranes at 100V constant voltage for 1 hour. The resulting blots were  
incubated overnight at 4
0
C in blocking buffer (0.1% Tween-20 with 5% w/v nonfat dry milk in 
TBS), then incubated with cyclin B1 primary antibody (Cell Signaling Technology, Danvers, 
MA)  diluted in TBST (TBS, 0.1% Tween-20), with 5% BSA for 2.5 hours. The dilution for the 
cyclin B1 primary antibodies was 1:2000. The membrane was then incubated for 1.5 hrs with 
biotinylated secondary antibody conjugated with streptavidin-alkaline phosphatase anti-IgG 
(anti-mouse, Cell signaling technology, Danvers, MA). To visualize the bands, membranes were 
incubated with 10ml of nitro blue tetrazolium/5-bromo-4-chloro-3-indolyl-phosphate as substrate 
(Promega, Madison, WI).  Resultant blots were scanned and analyzed by ImageJ software. 
 
 
 
 
 
 
  
 
CHAPTER 3:  RESULTS 
3.1 EFFECT OF LOW DOSE RADIATION ON CELL SURVIVAL OF A375 AND PC3 
CELLS  
 
 The goal of these studies was to characterize the survival response following low dose 
radiation in two cell lines – the A375 human melanoma cell line and the PC3 prostate carcinoma 
cell line.  To achieve this, survival was assessed using the clonogenic assay.  As mentioned in the 
previous chapter, this assay essentially tests for reproductive integrity (the ability of a cell to 
undergo “unlimited” division) and has long been considered to be the method of choice to 
determine radiation-induced cell death. 
Figure 3.1 shows the survival curve of A375 cells relative to the untreated controls after 
irradiation with x-ray doses of 0, 2, 5, 10, 25, 50 and 100 cGy.  Cells were irradiated during 
exponential growth phase (~70% confluence) and the percentage of survival was determined 
using a standard clonogenic assay. Results are means of at least 8 independent experiments with 
quadruplets for each data point and error bars representing the standard error of the mean (SEM).  
Data show that, relative to unirradiated controls, survival was significantly increased in the A375 
cells following doses of 2 and 5 cGy (p-value ≤ 0.01), suggesting that these cells display hyper-
radioresistance in the very low dose range of radiation.  Specifically, irradiation with 2 cGy 
increased survival up to 110% compared to unirradiated controls, while 5 cGy increased survival 
to approximately 120% of unirradiated controls.  In contrast, the survival of A375 cells irradiated 
with doses above 10 cGy decreased as a function of increasing dose. 
Figure 3.2 shows the survival curve of the PC3 cells, also irradiated with doses between 0 
and 100 cGy.  As with the A375 cells, irradiations were performed during exponential growth 
phase (~70% confluence) and the percentage of survival was determined using a standard 
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clonogenic assay. Results are means of at least 6 independent experiments with quadruplets for 
each data point and error bars representing the standard error of the mean.  Results demonstrate 
that, in contrast to the A375 cells, survival of PC3 cells following irradiation with 2 and 5 cGy 
was significantly decreased relative to unirradiated controls (p-value ≤ 0.01). This hyper-
radiosensitivity response was significant with survival being reduced as much as 15 and 20% 
following 2 and 5 cGy, respectively.  Similar to A375 cells, at doses greater than 10 cGy, PC3 
cell survival also decreased as a function of increasing dose. 
Figure 3.3 is a combined plot of survival curves for A375 and PC3 cells to allow for easy 
comparison of the differential responses that these two cell lines demonstrate following exposure 
to doses of radiation in the very low dose range.  Additionally, this figure also demonstrates that 
the PC3 cell line appears to be more radiosensitive than the A375 cell line over the entire range 
of doses investigated (0 – 100 cGy), thereby confirming the numerous reports demonstrating 
marked cell type differences in response to radiation.   
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Figure 3.1.  Cell survival curve of human melanoma A375 cells over a dose range of 0 and 100 
cGy demonstrating hyper-radioresistance in the very low dose range of radiation. 
 
 
 
 
Figure 3.2. Cell survival curve of human prostate cancer PC3 cells over a dose range of 0 and 
100 cGy demonstrating hyper-radiosensitivity in the very low dose range of radiation.  
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Figure 3.3.  Comparison of cell survival curves for human melanoma A375 cells and human 
prostate cancer PC3 cells over a dose range of 0-100 cGy demonstrating the differential pattern 
of response for these two cell lines at radiation doses between 0 and 100 cGy. 
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3.2 TEMPORAL KINETICS OF CELL CYCLE DISTRIBUTION FREQUENCIES 
FOLLOWING IRRADIATION 
 
 To investigate whether cell cycle changes were correlated with the observed hyper-
radioresistance in the A375 cells and hyper-radiosensitivity in the PC3 cells, flow cytometric 
analysis was performed to measure nuclear DNA content of experimental cell populations at 
various intervals over a 24 hour period following a radiation stress.  Following flow cytometric 
acquisition of data, ModFit software was used to analyze the DNA content of the cell samples 
and determine the relative distribution of cells in the G0/G1, S, and G2/M phases of the cell 
cycle.  Results are presented in Figures 3.4 and 3.5 with all values being expressed as 
percentages of unirradiated controls, and all data points representing the mean (±SEM) of three 
individual studies. 
Figure 3.4 shows the relative distribution of irradiated human melanoma A375 cells in 
G0/G1, S, and G2/M phases of the cell cycle as a function of time up to 24 hours.  Results 
demonstrate that, for cells exposed to 2 cGy (Figure 3.4, panel A), there was a significant 
accumulation of cells in the G2/M phase between 2 and 12 hours post irradiation, indicating a 
marked cell cycle block was occurring at this time.  Between 12 and 24 hours post irradiation, 
release of the block and a return to pre-irradiated control levels was observed.  In addition,  panel 
A also shows that, between 12 and 24 hours post irradiation, there is a modest increase in cells 
residing in the G0/G1 phase and a small decrease in cells within S phase.  While these changes 
did not prove to be statistically significant at this dose exposure, they are temporally correlated 
with the release of the G2/M block, and may represent radiation-induced cell sychronization 
(synchronization is brought about by the „piling up‟ of cells at the G2/M block, so that a large 
cohort of cells travels into the G0/G1 phase at the same time and transits through the rest of the 
cell cycle together)(134). 
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A375 cells irradiated with 5 cGy (Figure 3.4, panel B) followed a similar pattern of cell 
cycle progression as cells irradiated with 2 cGy, in that a pronounced G2/M block was observed 
to occur between 2 and 12 hours post irradiation.  As with the 2 cGy exposure, release of the 
block and return to control levels by 24 hours is also observed following this radiation dose.  Of 
interest as well, is the observation that, correlated with the release of the G2/M block, there is a 
significant increase in cells present in the G0/G1 phase and a reduction of cells present in S 
phase of the cell cycle between 12 and 24 hours post irradiation.  As stated above for the cell 
response to 2 cGy, these changes in G0/G1 and S phase are most likely a manifestation of the 
radiation-induced phenomenon of cell sychronization.  Further evidence of this can be derived 
from the observation that increased G0/G1 and decreased S phases are observed from 12 to 24 
hours post irradiation following any dose that displays a pattern of increased G2/M accumulation 
within the first 12 hours post irradiation (Figure 3.4, panels A, B, D, E, F). 
The relative distribution of  A375 cells following 10 cGy of  irradiation as a function of 
time  up to 24 hours is displayed in panel C.  In contrast to cells exposed to 2 and 5 cGy, results 
from these A375 cell studies demonstrate that essentially no changes in the accumulation of cells 
in any cell cycle phase is observed following 10 cGy, thereby suggesting that radiation-induced 
cell cycle arrest is not occurring in any of the three phases monitored over the 24 hour interval 
investigated.  Additionally, within the A375 population studied, no cell synchronization event 
appears to be present following this radiation dose exposure, since no increases in the G0/G1 
phase or concomitant decreases in S phase between 12 and 24 hours is observed.  
Following a 25 cGy exposure (Figure 4, panel D), small fluctuations in the accumulation 
of cells in G2/M appear during the first twelve hours following irradiation.  However, the 
changes monitored did not prove to be statistically different from control levels, so it is difficult 
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to determine whether a slight cell cycle arrest is occurring at this time or  not.  What is apparent 
from the data in panel D is that, similar to the 5 cGy irradiation exposure, statistically significant 
increases of cells in G0/G1 phase and decreases of cells in S phase are present at 24 hours post 
irradiation, which suggests that a synchronized cohort of cells is traversing through the G0/G1 
phase of the cell cycle during this time.  
 Finally, the relative cell cycle distribution of human melanoma A375 cells following 50 
cGy and 100 cGy as a function of time up to 24 hours are presented in panels E and F, 
respectively.  For cells irradiated with these higher doses of radiation, there is a return to the 
pattern seen following 2 and 5 cGy irradiation in that a significant accumulation of cells in the 
G2/M phase is observed, suggesting that cell cycle arrest is occurring.  Following 50 cGy, the 
interval of this arrrest occurred between 2 and 12 hours, while after a 100 cGy exposure, the 
arrest appeared to come on more slowly, but last over a longer period of time (4 – 24 hours).  
Increases in the level of G0/G1 and decreases in the level of S phase accumulation between 12 
and 24 hours post irradiation were also seen at these dose exposures, suggesting that a 
synchronized cohort of cells is present. 
Overall therefore, results displayed in Figure 3.4 suggest there is a marked, biphasic 
G2/M block in A375 cells following irradiation, with both very low doses (2 and 5 cGy) and 
higher doses (50 and 100 cGy) demonstrating a pronounce G2/M cell cycle arrest, while doses 
between these extremes (10 and 25 cGy) exhibit little-to-no block.  Results also demonstrate the 
presence of a radiation-induced synchronization of the cell population may be present in those 
cells exhibiting a cell cycle block.   
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Figure 3.4.  Relative distribution of human melanoma A375 cells in G0/G1, S, and G2/M  cell 
cycle phases following irradiation with 2-100 cGy (panels A-F).  Data points represent the mean 
(±SEM) of three individual studies analyzed flow cytometrically over a 24 hour interval post 
irradiation.  Data suggest the presence of a marked biphasic pattern in the frequency of cells 
undergoing G2/M arrest.  
Radiation-Induced Temporal Changes in A375 Cell Cycle Distribution 
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The relative distribution of PC3 cells following irradiation as a function of time up to 24 
hours is presented in Figure 3.5, and the marked differences between this cell line‟s response to 
radiation and the A375 cell line‟s radioresponse is readily apparent.  Indeed, following 2 cGy 
and 5 cGy, radiation doses which brought about a strong G2/M block in the A375 cell line 
between 2 and 12 hours post irradiation, PC3 cells (Figure 3.5, panel A & B) demonstrated no 
appreciable accumulation of cells in any of the three phases of the cell cycle monitored.  
Furthermore, similar to the 2 cGy and 5 cGy exposures, the relative distribution of PC3 cells in 
the various cell cycle phases (panel C) following 10 cGy demonstrated no statistically significant 
changes in accumulation throughout the 24 hour time period monitored.  Finally, over the 24 
hour period observed, not only was a lack of cell cycle arrest observed at these very low doses of 
10 cGy and below, but the PC3 cells also did not display the pattern of increased cells present in 
G0/G1 and decreased cells present in S phase that is typical of a radiation-induced cell 
synchronization event. 
However, at doses higher than 10 cGy, small fluctuations in the accumulation of cells in 
the G2/M phase can be observed between 2 and 12 hours following 25 cGy (Figure 3.5, panel C) 
and 50 cGy (Figure 3.5, panel E) exposures.  The minor increase in accumulation of cells in 
G2/M following a 25 cGy exposure did not prove to be statistically significant when compared to 
unirradiated controls, but is, perhaps, indicative of the beginning of a G2/M cell cycle arrest.  
However, the G2/M accumulation following a 50 cGy exposure was statistically significant at 8 
hours post irradiation, suggesting a small G2/M block is present.  In addition, an increase in S 
phase accumulation is also seen following exposure to 50 cGy, but the increase in this cell cycle 
phase is also not statistically significant.  As with the PC3 cell cycle distributions following the 
lower doses of radiation discussed above, exposure to 25 cGy and 50 cGy doses of radiation did 
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not result in statistically significant elevations of cells in G0/G1 phase or statistically decreased 
cells in S phase of the cell cycle between 12 and 24 hours post irradiation, suggesting the lack of 
a synchronized cohort of cells. 
Finally, PC3 cells irradiated with 100 cGy exhibited a G2/M block, with significant 
accumulation of cells in the G2/M phase occurring between 2 and 12 hours following irradiation.  
While significant, however, the G2/M accumulation observed for PC3 cells at this dose was not 
as pronounced as any of the G2/M blocks observed following irradiation of the A375 cell line 
(Figure 3.4, panels A, B, E, F).   However, similar to the A375 cell studies, the release of this 
block is temporally correlated with a small, but significant increase of cells in G0/G1 phase and a 
decrease of cells found in the S phase, suggesting some synchronization of the population has 
occurred.  
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Figure 3.5.  Relative distribution of human prostate cancer PC3 cells in G0/G1, S, and G2/M  
cell cycle phases following irradiation with 2-100 cGy.  Data points represent the mean (±SEM) 
of three studies analyzed flow cytometrically over a 24 hour interval post irradiation.  Results 
suggest that a marked cycle arrest is seen only following 100 cGy, occurring in the G2/M phase 
(panel F).  
Radiation-Induced Temporal Changes in PC3 Cell Cycle Distribution 
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3.3 COMPARISON OF RADIATION-INDUCED CELL CYCLE DISTRIBUTIONS IN 
A375 AND PC3 CELLS 
 
To facilitate comparison of the differential radiation-induced cell cycle responses 
between A375 human melanoma and prostate cancer PC3 cell lines, the relative distribution data 
for each of the cell cycle phases is presented as a function of cell type in Figures 3.6, 3.7 & 3.8.  
These data demonstrate that cell specific differences between the A375 and PC3 cell line exist 
for each cell cycle phase studied, but by far the most significant variations observed occur in the 
ability of the two cell lines to arrest in the G2/M phase.  Indeed, comparison of the two G2/M 
curves displayed in Figure 3.6 suggests a highly divergent response to radiation, particularly 
within the very low dose range (0 – 10 cGy).   For A375 cells, there exists a marked biphasic 
pattern in the frequency of cells accumulating in G2/M, with both very low doses (2 cGy and 5 
cGy), and higher doses (50 and 100 cGy) exhibiting significant cell cycle arrest, but with 
intermediate doses (10 and 25 cGy) exhibiting little-to-no G2/M block.  In sharp contrast to this 
radioresponse, no accumulation of cells in G2/M is observed in the PC3 cell line at or below 10 
cGy, suggesting that exposures at such low doses do not induce a cell cycle block.  Only at 25 
cGy and above are fluctuations in the accumulation of cells in G2/M observed within the PC3 
cell lines which may be suggestive of a cell cycle arrest, and, even then, statistically significant 
G2/M accumulations are seen only following 50 and 100 cGy exposures.  
As with the results presented for the G2/M phase in Figure 3.6, comparisons of G0/G1 
and S phase frequency distributions over a 24 hour interval following radiation (Figures 3.7 and 
3.8) also demonstrate cell specific differences, but neither cell line undergoes a radiation-induced 
cell cycle block in either G0/G1 or S phase at any of the doses investigated in this study.  Rather, 
the cell line specific differences for these two cell lines appear to be moderate in magnitude and 
often statistically insignificant.  Further, when they do occur, they tend to be more pronounced in 
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the latter part of the time interval monitored rather than the earlier hours post irradiation where 
the marked G2/M accumulations occurred, and may represent variances between these two cell 
lines in the induction of radiation-induced cell synchrony. 
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Figure 3.6.  Comparison of G2/M phase frequencies in A375 and PC3 cells following irradiation 
as a function of cell type.  Data are expressed as a percent of control, and demonstrate the 
marked differences in the ability of these two cell lines to arrest in the G2/M phase, especially in 
the very low dose range of radiation.  
Comparison of G2/M Phase Distribution Following Radiation 
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Figure 3.7.  Comparison of G0/G1 phase frequency distributions following radiation as a 
function of cell type.  Data are expressed as a percent of control, and demonstrate that cell 
specific differences between the A375 and PC3 cells exist, but neither cell line undergoes a 
G0/G1 phase cell cycle block following radiation.   
Comparison of G0/G1 Phase Distribution Following Radiation 
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Figure 3.8.  Comparison of S phase frequency distributions following radiation as a function of 
cell type.  Data are expressed as a percent of control, and demonstrate that cell specific 
differences between the A375 and PC3 cells exist, but neither cell line undergoes a S phase cell 
cycle block following radiation.  
Comparison of S Phase Distribution Following Radiation 
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3.4 EXPRESSION OF CYCLIN B1 LEVELS 
The aim of these studies was to correlate the temporal changes in cell cycle distribution 
frequencies described in Sections 3.2 and 3.3 with alterations in the expression of cell cycle 
regulatory proteins within the cell.  Because the dominant changes occurring in the flow 
cytometric studies of cell cycle frequency distribution were in the differential induction of the 
G2/M block, focus was placed upon monitoring G2/M arrest through the measurement of 
alterations in cyclin B1 levels within the human melanoma A375 and the prostate cancer PC3 
cell lines over a 24 hour period following irradiation.  
Figure 3.9 demonstrates the changes in the relative levels of cyclin B1 protein for A375 
and PC3 cells exposed to 2 cGy of irradiation (top panels display the Western blot bands of 
protein, while the bottom panels represent the relative band intensity as analyzed by ImageJ 
software.  As can be seen, in A375 cells, exposure to 2 cGy is correlated with a marked decrease 
of cyclin B1 levels at 4 and 6 hours post irradiation.  Thereafter, cyclin B1 levels return to hover 
around control levels for the remaining time interval monitored.  In contrast to the A375 cell 
data, PC3 cells exposed to 2 cGy demonstrate random fluctuations throughout the 24 hour 
interval, but no reduced levels which would be indicative of a G2/M arrest were apparent.  
Overall, therefore, G2/M cell cycle responses following exposure to 2 cGy, as assayed by 
Western blot analysis of cyclin B1 levels, produced results similar to the frequency distribution 
studies displayed in panel A of Figure 3.6, in that a radiation-induced G2/M block is observed in 
the A375 cell line, but not in the PC3 cell line.  However, the duration of the cyclin B1reduction 
following radiation of A375 cells was much shorter than the G2/M block observed by the flow 
cytometric data.  
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Figure 3.10 demonstrates the changes in the relative levels of cyclin B1 protein for A375 
and PC3 cells exposed to 5 cGy of irradiation.  As in Figure 3.9, the top panels display the 
Western blot bands of protein, while the bottom panels represent the relative band intensity as 
analyzed by ImageJ software.  As can be seen, in A375 cells, exposure to 5 cGy is correlated 
with a marked decrease of cyclin B1 levels between 2 and 6 hours post irradiation, followed by a 
return toward control levels between 8 and 12 hours post irradiation.  Of interest, a second 
reduction of cyclin B1 at 24 hours post irradiation is also seen, which is most likely due to the 
cohort of synchronized cells present in G0/G1 at this time (Figure 3.7. Panel B), since levels of 
cyclin B1 are naturally quite low in the G0/G1 cell cycle phase (see Figure 1.2 in Chapter 1).  In 
contrast to the A375 cell response, PC3 cells exposed to 5 cGy demonstrate only small 
fluctuations throughout the 24 hour interval, and displayed no evidence of reduced levels that 
would suggest the occurrence of a G2/M arrest.  In summary, therefore, the G2/M cell cycle 
responses following exposure to 5 cGy, as assayed by Western blot analysis of cyclin B1 levels, 
were similar in pattern to the frequency distribution studies displayed in panel B of Figure 3.6, in 
that a radiation-induced G2/M block is observed in the A375 cell line, but not in the PC3 cell 
line.  Furthermore, unlike the case for 2 cGy described above, the duration of the cyclin B1 
reduction is similar to the flow cytometric data although the onset is earlier (2 hours post 
irradiation). 
Figure 3.11 displays the changes in the relative levels of cyclin B1 protein for A375 and 
PC3 cells exposed to 10 cGy of irradiation.  As in the previous two figures, the top panels 
display the Western blot bands of protein, while the bottom panels represent the relative band 
intensity as analyzed by ImageJ software.  At this radiation dose, both the A375 and the PC3 cell 
lines demonstrate only small fluctuations in the levels of cyclin B1 throughout the cell cycle.  No 
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evidence of reduced levels indicative of a G2/M block are observed.  This response is in 
correlation with the lack of cell cycle arrest at this low dose seen in the flow cytometric studies 
(Figure 3.6, panels C & D). 
Changes in the relative levels of cyclin B1 protein for A375 and PC3 cells exposed to 25 
cGy of irradiation are presented in Figure 3.12.  Similar to the 10 cGy response, following 
irradiation at this dose, A375 cells demonstrate only small fluctuations in the levels of cyclin B1 
throughout the cell cycle, with no evidence of a G2/M block being observed.  These results 
correlate with the flow cytometric studies on A375 cells presented previously (Figure 3.6, panel 
D).  In contrast, while no statistically significant block in G2/M is observed in PC3 cell from the 
flow cytometric studies (Figure 3.6, panel D), Western blot analysis of PC3 cell response to 25 
cGy irradiation displays a short-lived reduction of cyclin B1 levels at 2 hours post irradiation 
which may correspond to G2/M block. 
Figure 3.13 demonstrates the changes in the relative levels of cyclin B1 protein for A375 
and PC3 cells exposed to 50 cGy of irradiation.  As can be seen, the data in both of these cell 
lines following irradiation indicate that a G2/M cell cycle arrest is occurring, since, in both cell 
lines, a greater than two-fold decrease in cyclin B1 levels at 2 and 4 hours post irradiation is 
observed.  As following 25 cGy (Figure 3.12), for the A375 cells, this response correlates with 
the flow cytometric studies on A375 cells presented in Figure 3.6 (panel E), although the 
duration of the cyclin B1 reduction is much shorter than the G2/M block seen in the flow 
cytometric studies.  In additon, the onset and duration of the marked G2/M block seen with 
Western blot analysis of PC3 cells following 50 cGy irradiation is in contrast with the G2/M cell 
cycle data observed from the flow cytometric studies (Figure 3.6, panel E), which, while 
suggesting a small G2/M accumulation may be occurring, did not show a statistically significant 
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pattern of G2/M arrest except at 8 hours post irradiation. Also of interest following 50 cGy is the 
observation that the G2/M block occurring at 2 and 4 hours post irradiation is followed in both 
cell lines with pronounced increase in cyclin B1 levels to above control levels by 6 hours post 
irradiation, and, then, a second decline in their levels over the remaining time interval monitored, 
so that, by 24 hours post irradiation, both the A375 and PC3 cell lines show a sharp drop in 
cyclin B1 levels compared to unirradiated controls.  As stated above, this second reduction of 
cyclin B1 at 24 hours post irradiation is most likely due to the fact that, due to the phenomenon 
of radiation-induced synchrony, most of the cells are present in a phase of the cell cycle where 
the levels of cyclin B1 are naturally quite low, such as G0/G1 phase or early S phase (see Figure 
1.2 in Chapter 1). 
Figure 3.14 demonstrates the changes in the relative levels of cyclin B1 protein for A375 
and PC3 cells exposed to 100 cGy of irradiation.  As observed following a 50 cGy exposure 
(Figure 3.12), the data in both of these cell lines following irradiation indicate that a G2/M cell 
cycle arrest is occurring (although  the onset at 2 hours coming sooner than the flow cytometric 
evidence indicating an onset of 4 hours for the G2/M arrest, and the duration of the of the cyclin 
B1 reduction was much shorter than the G2/M accumulation was using the flow cytometric 
data).  The PC3 response following 100 cGy is highly similar in both magnitude and timing as 
seen following a 50 cGy exposure.  However, in the A375 cells, differences do exist.  Following 
100 cGy, the G2/M block is of longer duration than that observed following 50 cGy exposure, 
with cyclin B1 levels being reduced through 8 hours post irradiation.  Only by 12 hours post 
irradiation do cyclin B1 levels return to control.  Furthermore, unlike the 50 cGy studies, for both 
cell lines, the strong G2/M block observed using Western blot analysis correlates with the the 
flow cytometric studies presented in panel F of Figure 3.6 that suggest a significant radiation-
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induced G2/M arrest is present.  Finally, as seen following a 50 cGy exposure, both the A375 
and PC3 cell lines show a sharp drop in cyclin B1 levels compared to unirradiated controls by 24 
hours post irradiation, which is likely due to radiation-induced synchrony of the cell populations 
so that most of the cells are present in a phase of the cell cycle where the levels of cyclin B1 are 
naturally quite low (see Figure 1.2 in Chapter 1). 
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Cyclin B1 Levels Following 2 cGy Irradiation 
 
Figure 3.9.  Changes in the relative levels of cyclin B1 protein over a 24-hour time interval for 
A375 and PC3 cells exposed to 2 cGy of irradiation.  Top panels display the Western blot bands 
of protein, while the bottom panels represent the relative band intensity as analyzed by ImageJ 
software.  Data demonstrate a reduction in cyclin B1 levels in A375 cells, but not in PC3 cells. 
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Cyclin B1 Levels Following 5 cGy Irradiation 
 
Figure 3.10.  Changes in the relative levels of cyclin B1 protein over a 24-hour time interval for 
A375 and PC3 cells exposed to 5 cGy of irradiation.  Top panels display the Western blot bands 
of protein, while the bottom panels represent the band intensity (relative to control) as analyzed 
by ImageJ software.  Data demonstrate a reduction in cyclin B1 levels in A375 cells, but not in 
PC3 cells. 
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Cyclin B1 Levels Following 10 cGy Irradiation 
 
Figure 3.11.  Changes in the relative levels of cyclin B1 protein over a 24-hour time interval for 
A375 and PC3 cells exposed to 10 cGy of irradiation.  Top panels display the Western blot bands 
of protein, while the bottom panels represent the band intensity (relative to control) as analyzed 
by ImageJ software.  Data display some fluctuations, but no significant reduction, in cyclin B1 
levels for A375 or PC3 cells. 
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Cyclin B1 Levels Following 25 cGy Irradiation 
 
Figure 3.12.  Changes in the relative levels of cyclin B1 protein over a 24-hour time interval for 
A375 and PC3 cells exposed to 25 cGy of irradiation.  Top panels display the Western blot bands 
of protein, while the bottom panels represent the band intensity (relative to control) as analyzed 
by ImageJ software.  Data display some fluctuations, but no significant reduction, in cyclin B1 
levels for A375 or PC3 cells. 
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Cyclin B1 Levels Following 50 cGy Irradiation 
 
 
Figure 3.13.  Changes in the relative levels of cyclin B1 protein over a 24-hour time interval for 
A375 and PC3 cells exposed to 50 cGy of irradiation.  Top panels display the Western blot bands 
of protein, while the bottom panels represent the band intensity (relative to control) as analyzed 
by ImageJ software.  Data demonstrate a significant reduction in cyclin B1 levels for both A375 
and PC3 cells. 
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Cyclin B1 Levels Following 100 cGy Irradiation 
 
Figure 3.14.  Changes in the relative levels of cyclin B1 protein over a 24-hour time interval for 
A375 and PC3 cells exposed to 100 cGy of irradiation.  Top panels display the Western blot 
bands of protein, while the bottom panels represent the band intensity (relative to control) as 
analyzed by ImageJ software.  Data demonstrate a significant reduction in cyclin B1 levels for 
both A375 and PC3 cells. 
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3.5 EXPRESSION OF ACTIVATED MAPKS AND NF-KB 
Exposure to radiation has been reported to trigger upregulation of proliferative signaling 
cascades such as the MAPK and NF-κB pathways.  Therefore, studies were undertaken to 
ascertain whether signaling through these proliferative pathways is being activated following 
exposure of A375 and PC3 cells to low doses of radiation.  These studies were accomplished by 
monitoring the levels of phosphorylated (activated) ERK1/2, JNK1/2, p38 and NF-κB using cell-
based ELISA assays that were performed 5 hours post irradiation (preliminary studies in our 
laboratory determined this time to be optimal).  All results represent the mean ± SEM of three 
independent experiments on triplicate samples which have been converted to fraction of 
unirradiated control.  
Figure 3.15 shows the protein levels of phosphorylated EKR1/2 in A375 and PC3 cells 
following irradiation at doses of 0 - 100 cGy.  Results demonstrate a pattern of increased levels 
of phosphorylated ERK1/2 as a function of increasing dose for both cell lines, with statistically 
significant increases in phosphorylated protein levels occurring between 25 and 100 cGy both in 
the A375 and PC3 cell lines, suggesting an activation of this signaling cascade at these radiation 
doses. 
As can be seen in Figure 3.16 which displays the change in expression of phosphorylated 
JNK1/2 in the A375 or the PC3 cell lines following exposure to radiation, levels were maximally 
elevated at exposure doses of 10 and 25 cGy.  In both the A375 melanoma and the PC3 prostate 
carcinoma cell line, these increases were statistically significant at these doses.   
 Figure 3.17 shows the protein levels of phosphorylated p38 levels in A375 and PC3 cells 
following irradiation at doses of 0 - 100 cGy.  In both A375 and PC3 cells, fluctuations in protein 
levels were observed.  However, relative to unirradiated controls, there were no statistically 
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significant radiation-induced changes in phosphorylated p38 levels observed over the dose range 
investigated. 
 Finally, Figure 3.18 displays the relative induction of phosphorylated NF-κB obtained 
following exposure to low dose radiation.  As can be observed, results for the A375 cells 
demonstrate that the levels of phosphorylated NF-κB remain similar to control following 
irradiation with very low doses, but from 10 – 50 cGy exposures, phosphorylation of NF-κB is 
significantly down-regulated relative to the unirradiated controls.  This pattern is not observed in 
the PC3 cell line where phosphorylated protein levels fluctuate but do not demonstrate 
statistically significant changes except following 5 cGy where levels are down-regulated.  
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Phosphorylation of ERK1/2 as a Function of Radiation Dose 
 
 
 
Figure 3.15  Relative induction of phosphorylated ERK1/2 obtained from a cell-based ELISA 
assay performed 5 hours following x-irradiation.  Results represent the mean ± SEM of three 
independent experiments on triplicate samples which have been converted to fraction of control.  
Data suggest an increasing pattern of activation as a function of increasing dose.  Asterisks 
connote data points significantly different from control. 
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Phosphorylation of JNK1/2 as a Function of Radiation Dose 
 
Figure 3.16  Relative induction of phosphorylated JNK1/2 obtained from a cell-based ELISA 
assay performed 5 hours following x-irradiation.  Results represent the mean ± SEM of three 
independent experiments on triplicate samples which have been converted to fraction of control.  
Data demonstrate the presence of elevated levels following 10 and 25 cGy exposures in both cell 
lines.  Asterisks connote data points significantly different from control. 
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Phosphorylation of P38 as a Function of Radiation Dose 
 
Figure 3.17  Relative induction of phosphorylated p38 obtained from a cell-based ELISA assay 
performed 5 hours following x-irradiation.  Results represent the mean ± SEM of three 
independent experiments on triplicate samples which have been converted to fraction of control. 
Data display fluctuations in the levels of phosphorylated p38, but not significant changes are 
observed in either cell line. 
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Phosphorylation of NF-κB as a Function of Radiation Dose 
 
 
Figure 3.18  Relative induction of phosphorylated NF-κB obtained from a cell-based ELISA 
assay performed 5 hours following x-irradiation.  Results represent the mean ± SEM of three 
independent experiments on triplicate samples which have been converted to fraction of control.  
Data demonstrate that the levels of phosphorylated NF-κB are significantly down-regulated 
following exposures from 10 to 50 cGy in the A375 cell line, but not in the PC3 cell line.  
Asterisks connote data points significantly different from control. 
 
  
  
 
CHAPTER 4:  DISCUSSION 
4.1 SURVIVAL OF A375 AND PC3 CELLS FOLLOWING LOW DOSE RADIATION 
Over the past two decades, increasing evidence has been accumulating suggesting that 
exposure of cells to very low dose (VLD) radiation results in a host of unpredictable responses 
(e.g. adaptive responses, bystander effects and inverse dose rate effects), making it clear that 
extrapolation of data derived from high dose studies to this very low dose region is no longer a 
feasible alternative.  As a consequence, therefore, one goal of these studies was to characterize 
the response of two different cell lines, the human melanoma A375 cell line and the human 
prostate cancer PC3 cell line, following exposure to the low dose range of radiation.  These two 
cell lines were selected because they represent the opposite ends of the spectrum with regard to 
radiation sensitivity.  For example, in classical dose-response survival studies (1 Gy and greater), 
the A375 cells have been shown to be moderately resistant to radiation, while the PC3 cells have 
been shown to be relatively sensitive to radiation (135).  In addition, preliminary studies within 
our laboratory suggested that the human melanoma A375 cell line appeared to demonstrate an 
interval of hyper-radioradioresistance following very low doses of radiation.  This response was 
in sharp contrast to reported literature that argued that PC3 cells display very low dose hyper-
radiosensensitivity (125).  It was felt, therefore, that comparing and contrasting the radioresponse 
profiles of these two lines, both at the cellular level (survival) and the molecular level (cell 
signaling pathways), might help better elucidate the mechanisms underlying the often-times 
contradictory cellular responses to low dose radiation.  
As stated above, the goal of this series of studies was to characterize the survival 
response of the human melanoma A375 cell line and the human prostate cancer PC3 cell line 
following exposure to the low dose range of radiation.  The results of these studies demonstrated 
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two very different survival responses to very low dose irradiation (10 cGy and below) were 
present, neither of which followed classical linear quadratric theory.  Specifically, the results of 
this investigation demonstrated that clonogenic survival is significantly increased in A375 cells 
when irradiated at doses between 2–5 cGy, suggesting that this cell line demonstrates low dose 
hyper-radioresistance.  Conversely, clonogenic survival in the PC3 cells is significantly 
decreased at 2-5 cGy,  suggesting a low dose hyper-radiosensitivity response exists.  Finally, the 
results show that this phenomenon of increased radioresistance versus increased radiosensitivity 
in A375 and PC3 cells, respectively, occurrs only at the very low doses of radiation studied in 
this investigation (less than 10 cGy).  At doses higher than 25cGy, both cell lines began to 
display a classical linear quadratic pattern of response to radiation. 
Regarding the results of the PC3 studies, the data confirm previous reports of hyper-
radiosensitivity in PC3 cells that have been demonstrated using both the conventional colony 
formation assays (135) and by flow cytometric methods (136).  Indeed, several reports published 
in the last two decades have demonstrated that many mammalian cell lines exhibit hyper-
radiosensitivity in the low dose range of radiation (17, 92, 96, 97, 137).  For example, Wouters et 
al demonstrated that U1 melanoma, DU 145 prostate carcinoma, HT-29 colon adenocarcinoma, 
SiHA cervical squamous carcinoma and A549 lung adenocarcinoma cell lines exhibited low dose 
hyper-radiosensitivity (17).  Additionally, Schettino et al reported low dose hyper-
radiosensitivity in Chinese Hamster V79 cells (13). 
The reasons for this increased sensitivity at low doses still remain to be clearly defined, 
although some investigators suggest that the failure to induce protective mechanisms such as cell 
cycle arrest may play a role. Another currently popular explanation given for the hyper-
radiosensensitivity observed at very low doses is that cells need to accumulate some minimum 
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damage before DNA repair mechanism are turned on (56).  If DNA damage is below this 
minimum amount, there is no upregulation of repair pathways and the damage remains within 
the cell, weakening it.  In support of this damage threshold theory, it was observed that cells pre-
treated with very low concentrations of hydrogen peroxide before irradiation did not display the 
hyper-radiosensensitivity seen in irradiated-only cells (127), because the DNA damage from 
hydrogen peroxide added on to the DNA damage from the radiation to surpass the damage 
threshold required for the activation of DNA repair pathways.  However, not all researchers 
currently support the DNA damage threshold concept, arguing that most of these studies have 
not been based on direct measurement of DNA double strand breaks, but, rather, indirect 
estimates of DNA damage, such as the measurement of γ-H2AX foci, that may be prone to error 
(128). 
In contrast to low dose hyper-radiosensitivity responses, results from the A375 
experiments suggest that hyper-radioresistance is occurring following exposure to very low 
doses of radiation for this cell line.  Furthermore, to the best of my knowledge, this is the first 
report documenting a low dose hyper-radioresistant response in A375 cells.  However, a small 
fraction of other cell lines have been reported to display increased survival or hyper-
radioresistance following low dose irradiation.  For example, Kim et al demonstrated that a dose 
of 5 cGy stimulated proliferation in CCD 18Lu human lung fibroblasts (20), whereas Suzuki et 
al reported enhanced proliferation in normal human diploid (HE49) cells (19).  As with the 
induction of hyper-raidosensitivity, the mechanisms responsible for observed hyper-
radioresistance are still poorly understood.  However, in addition to DNA damage, radiation-
induced membrane-associated changes occur following irradiation of cells, which can induce the 
activation of major growth regulators such as epidermal growth factor receptors (EGFR), tumor 
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necrosis factor receptors (TNFR) and tyrosine kinase receptors (3, 61, 69, 78), and some 
researchers have suggested that the mechanism underlying low dose hyper-radioresistance may 
be due to a hyper-proliferative response brought about by the activation of these important 
growth factors and subsequent stimulation of proliferative pathways.  For example, activation of 
the EGFR in the plasma membrane has been associated with stimulation of the MAPK pathways 
(78, 79) which, as described previously, are important mediators of enhanced cell 
proliferation/survival.  Additionally, in Chinese hamster fibroblasts and Raji lymphoma cells 
irradiated at doses between 2 and 10 cGy, a pronounced hyper-proliferative response was 
observed (130).   Furthermore, irradiation at doses between 2 and 5 cGy has been documented to 
cause hyper-proliferation in normal human HE49 cells (19).  Finally, exposure to 50 cGy has 
been reported to stimulate induction of cell proliferation in mouse hematopoietic cells (21), and 
irradiation at 5 cGy has been shown to enhance cell proliferation via transient ERK1/2 and p38 
activation in normal human lung fibroblasts (20). 
In conclusion, therefore, the results of these cell survival studies add to the increasing 
body of evidence which suggest that the response to radiation at very low doses (0-10 cGy) is 
complex and cannot simply be extrapolated from the high dose range used in classical cell 
survival studies. Rather, these data demonstrate that response to very low dose radiation is often 
cell type specific and frequently contradictory. 
 
4.2 CELL CYCLE FREQUENCY DISTRIBUTIONS OF A375 AND PC3 CELLS 
FOLLOWING LOW DOSE RADIATION 
 
 Collectively, the results of the flow cytometric studies monitoring the cell cycle 
frequency distributions of A375 and PC3 cells demonstrated the following:  (1) a G2/M block is 
seen in both cell lines at the higher doses studied; (2) a strong G2/M block is observed in A375 
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cells following exposure to 2 and 5 cGy which may contribute to the hyper-radioresistance seen 
in this cell line within this very low dose range; (3) no evidence of G2/M arrest is observed in 
PC3 cells following exposure to 2 and 5 cGy where radio-hypersensitivity is documented, 
suggesting that the lack of a G2/M arrest may be contributing to the hyper-radiosensitivity of this 
cell line within this very low dose range;  and (4) no significant evidence of G0/G1 or S phase 
arrest is seen in either cell line, but changes in G0/G1 and S accumulation by 24 hours post 
irradiation are present in those studies where the presence of an earlier G2/M block is seen, 
suggesting radiation-induced synchrony may be occurring.  
As stated above, these results confirm the existence of a G2/M block occurring following 
irradiation with doses of 50 or 100 cGy.  Since numerous studies have shown that radiation doses 
of about 50 cGy or higher interfere with normal progression of the cell cycle in a variety of cell 
lines (23, 25, 51), these results are not unexpected.  Indeed, cell cycle arrest after exposure to 
radiation is the norm, rather than the exception, with several studies documenting the presence of 
arrests in all three phases of the cell cycle following irradiation, although G2/M is the most 
commonly reported block (25, 50, 51, 138).  For example, for HeLa cells alone, separate studies 
have observed blocks in S phase after irradiation with 5 Gy (139), blocks in G2/M  phase after 
irradiation with doses between 0.34 and 1.35 Gy (31), and blocks in G1, S and G2/M phases 
following irradiation with 3 Gy (140).  Similarly, studies using Chinese hamster cells exposed to 
a series of doses between 1.5-6 Gy demonstrated dose dependent division delay in all three cell 
cycle phases (141).  Furthermore, the data from these studies demonstrating that the cell cycle is 
arresting in G2/M is also consistent with previous studies which confirm that the most frequently 
induced cell cycle arrest following radiation is seen in the G2/M phase (25, 49, 50).  Arrest at 
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this stage of the cell cycle is critical to repairing DNA before the cell enters mitosis, thereby 
reducing the potential for mitotic catastrophe. 
Our results also indicate that the magnitude and duration of the G2/M delay in both the 
A375 and PC3 cells were dose dependent and far more pronounced in the A375 line than in the 
PC3 line.  As evidenced from panels E and F of Figure 3.8, the PC3 cells irradiated with 100 cGy 
had a G2/M arrest that lasted from 2-12 hours and peaked at 170% of unirradiated control, while 
PC3 cells irradiated with 50 cGy had exhibited only small block between 4 and 12 hours which 
peaked at about 125% of unirradiated control values.  Similarly, although the peak accumulation 
in A375 cells for both 50 and 100 cGy was pronounced (~ 225% of control), the duration of the 
block following 100 cGy was longer, lasting between 4 and 24 hours, as compared to 2 -12 hours 
for the 50 cGy study.  These results are in agreement with numerous other studies performed at 
high doses that have demonstrated that the magnitude and recovery time for G2/M delays is 
proportional to dose administered, with higher doses exerting a longer and larger G2/M delay 
(142-144).  For example, Walters et al demonstrated that Chinese hamster ovary (CHO), HeLa 
S-3 and  murine lymphoma L-5178Y cells displayed a G2/M block that was proportional to dose 
(142), while Ehmann et al showed that for L5178YS /S leukemia mouse cells irradiated with 50, 
100, 200 and 300 cGy dose dependent G2/M arrests were observed, with 50 cGy showing the 
least in magnitude of arrest and time of delay, while the cells irradiated with 300 cGy had a 
longer time delay and higher percentage of cells in G2/M (144). 
  A second major finding of these studies is the observation that a strong G2/M block is 
observed in A375 cells in the very low dose range which may contribute to the hyper-
radioresistance seen at 2 and 5 cGy doses by allowing the cells time to repair before proceeding 
to mitosis.  Surprisingly, this block is not present following 10 and 25 cGy exposures, but, as 
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stated above, reappears following 50 and 100 cGy exposures.  What is causing this unusual 
pattern of G2/M arrest in A375 cells following irradiation is unclear, since cell cycle changes 
following low doses of radiation have not been well investigated.  However, the biphasic nature 
of the G2/M arrest may imply the presence of two separate mechanisms in play.  There are 
studies which suggest that very low dose radiation can modulate the expression of various genes 
related to cell cycle arrest in a manner quite different from that seen by higher radiation doses 
(145, 146).  In fact, studies by Ding et al demonstrated that in normal skin fibroblasts (HSF42) 
cells, 2 cGy exposures predominantly caused expression of genes involved in DNA damage 
response and signal transduction, while 400 cGy exposures predominantly induced expression of 
genes involved in proliferation and apoptosis (147).  Nevertherless, while it is reasonable to 
conclude that the G2/M arrest in A375 cells observed at 2 and 5 cGy may be playing a role in 
mediating the very low dose hyper-radioresistance seen through the facilitation of DNA repair 
before proceeding to mitosis, it must also be noted that most studies have postulated that the 
major mechanism underlying hyper-radioresistance following low dose radiation is increased 
proliferation mediated through activation of growth pathways such as the MAPK cascades (19, 
20). Certainly more studies are warranted in this area to better understand the basis of this 
radioresistant phenomenon. 
A third major finding of these studies was the fact that the hyper-radiosensitivity 
observed in PC3 cells at very low doses appears to correlate with a lack of G2/M arrest at these 
doses.  Specifically, in this investigation, no evidence of G2/M arrest was observed in PC3 cells 
at the very low dose range (0-10 cGy), where hyper-radiosensitivity was seen.  Failure of PC3 
cells to exhibit cell cycle arrest at doses of maximal hyper-radiosensivity (2-10 cGy) is in general 
agreement with others (97, 148).  For example, Enns and colleagues demonstrated that A549 
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human lung carcinoma cells that displayed hyper-radiosensitivity following 5 and 10 cGy of 
radiation, failed to arrest in any of the cell cycle phases at these doses (97).  The precise 
mechanism underlying the inability of PC3 cells to arrest at these very low doses is unclear, but 
it is likely that the low level of DNA damage following such low doses of irradiation did not 
cause enough damage to trigger a G2-M arrest.  As discussed earlier, a currently well-accepted 
theory for the failure of hyper-radiosensitive cell lines to arrest at low doses is that cells need to 
accumulate some minimum DNA damage before DNA repair mechanisms are triggered (56).  If 
DNA damage is below this minimum, DNA repair pathways are not activated within the cell.  In 
support of the minimal DNA damage theory, it was observed that cells pre-treated with very low 
concentration of hydrogen peroxide before irradiation lost their hyper-radiosensitivity (127), 
presumably because the DNA damage from hydrogen peroxide added on to the DNA damage 
from the radiation to surpass the damage threshold required for the activation of DNA repair 
pathways.  Nevertheless, not all researchers currently support the DNA damage threshold 
concept, arguing that most DNA repair data from low dose radiation studies have been based on 
indirect estimates of DNA damage (measuring γ-H2AX foci) and not direct measurement of 
DNA double strand breaks (128).  More research is needed to elucidate mechanisms of low dose 
hyper-radiosensitivity. 
A final finding of the cycle frequency distribution studies was the lack of evidence to 
suggest that either cell line was arresting in G0/G1 or S phases of the cell cycle.  This finding 
was somewhat surprising, since several investigations have documented the presence of G1 
and/or S phase blocks following radiation exposure (12, 22, 27-29, 39, 41).  However, since 
these studies used radiation doses much higher than those used in this investigation, the disparity 
between these reports and the results of this study may be due to differential dose effects.  Of 
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interest, it has been noted by some investigators that G1 arrests, even when they are induced, 
may not play a major role in the mediation of radiation effects, and that transient delays in G1 
are likely not to have a significant impact on radiation survival (149, 150).  For instance, 
Slichenmyer et al demonstrated that, following exposure to a radiation stress, clonogenic survival 
for two colorectal cancer cell lines (SW480 cells which don‟t arrest in G1 and RKO cells which 
do arrest in G1) was not significantly different (149).   
 Although actual arrests were not observed in either cell line, changes in G0/G1 and S 
phase accumulation by 24 hours post irradiation were seen in those studies where the presence of 
an earlier G2/M block was found.  As stated earlier, these observations of increased G0/G1 phase 
numbers and decreased S phase numbers may be due to the phenomenon of radiation-induced 
synchrony.  Synchronization of cells after irradiation is a well-described event (151-153) in 
which a significant accumulation of cells in the G2/M phase is followed by release of the G2/M 
block and the movement of a large cohort of cells concurrently into G0/G1, where they progress 
through one of more cycles of cell division in tandem before reassorting into an asynchronous 
cell population again.  
 
4.3 CYCLIN B1 LEVELS IN A375 AND PC3 CELLS AFTER LOW DOSE RADIATION 
 One aim of these studies was to investigate the effect of low doses of radiation on the 
expression of cell cycle regulator proteins in the effort to correlate the temporal changes in cell 
cycle frequency distributions with the downregulation of cyclin levels.  Because the cell cycle 
arrests occurred only within the G2/M phase, therefore, studies were designed to monitor 
changes in this phase of the cell cycle by measuring cyclin B1 levels.  The rationale for choosing 
cyclin B1 is based on the crucial role that the cyclin B1/CDK1 complex plays in triggering the 
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progress of cells through the G2 and M phases of the cell cycle (25, 51, 154).  A decrease in 
cyclin B1 levels can lower the amount of cyclin B1/CDK1 complex present and, as such, can 
hinder entry into mitosis, leading to accumulation of cells in the G2/M phase (155-158). 
 Collectively, the results from these studies demonstrated the following:  (1) for A375 
cells, reductions in cyclin B1 levels were observed at both the very low (2 and 5 cGy) and the 
high (50 and 100 cGy) doses of radiation, but were not present following doses of 10 and 25 
cGy, confirming the observation made in the previous section that a biphasic G2/M block is 
occurring; (2) for PC3 cells irradiated with doses from 2-25 cGy, cyclin B1 levels fluctuated, but 
displayed no significant reduction, also agreeing with the flow cytometric frequency distribution 
studies; (3) PC3 cells irradiated with 50 cGy, showed a marked reduction in cyclin B1 activity, 
but the frequency distribution data for the 50 cGy exposure demonstrated only a small G2/M 
accumulation; (4) PC3 cells irradiated with 100 cGy, showed a marked reduction in cyclin B1 
activity which was in agreement with the frequency distribution data for the 100 cGy exposure 
seen in this cell line, and, finally, (5) when compared to the frequency distribution data obtained 
flow cytometrically, no consistent pattern in temporal onset and duration of cyclin B1 reductions 
could be seen.  Overall, however, although not always consistent, the results of these studies 
showed good agreement with the flow cytometric frequency distribution studies.  
Several reports have demonstrated that, for cells that display a G2 arrest, there exists a 
correlation between down regulation of cyclin B1 protein levels with accumulation of cells in the 
G2/M phase (51, 155, 159, 160).  For example, Hendrikse et al reported a decrease in cyclin B1 
levels in TK6 (a lymphoblast cell line) following 1 and 3 Gy of irradiation (161), while Muschel 
et al also reported a decrease in cyclin B1 subsequent to radiation in Hela Cells (159).  In 
addition, Enns et al correlated the lack of cyclin B1 decreases following irradiation with the 
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hyper-radiosensitivity observed in the A549 lung adenocarcinoma cell lines after irradiation with 
doses of less than 20 cGy (97), and Datta et al demonstrated a dose dependent down regulation 
of cyclin B1 in U937 leukemia cell line, after being irradiated with 1, 5 and 10 Gy of irradiation 
(162).  These data are in agreement with the above reports which suggest that a decrease in 
cyclin B1 levels can correlate with a G2/M block.  However, our results did not demonstrate a 
consistent pattern in the down-regulation of cyclin B1 protein levels with respect to either the 
onset or the duration of G2/M arrest as measured by the flow cytometric frequency distribution 
data.  For example, with regard to the duration of G2/M arrest, A375 cells displayed two distinct 
patterns of expression of cyclin B1 reduction.  Specifically, A375 cells irradiated with 2 and 50 
cGy displayed a short lived down-regulation of cyclin B1 protein, lasting less than six hours, 
while the flow cytometric data suggested a G2/M arrest of 12 or more hours in duration.  On the 
other hand, A375 cells following 5 and 100 cGy exposures displayed a prolonged cyclin B1 
reduction which was observed to last about 10 hours (2-12 hours post irradiation), a time interval 
more similar to what was seen in the flow cytometric data.  With regard to the onset of the cyclin 
B1 reduction, data also varied from the flow cytometric results.  For example, in A375 cells 
exposed to 5 and 100 cGy and PC3 cells exposed to 100 cGy, reduced levels of cyclin B1 were 
observed earlier than the G2/M accumulation as measured by flow cytometry, appearing at 2 
hours post irradiation, while flow cytometry data demonstrated significant accumulation 
beginning at 4 hours post irradiation.  However, following exposures of 2 cGy, the onset of 
cyclin B1 reduction occurred at 4 hours post irradiation in A375 cells, which was concurrent 
with the onset of G2/M accumulation observed in the flow cytometry studies, following a 50 cGy 
exposure, the rapid, and surprising, onset of G2/M arrest at one in the flow cytometry data 
appears earlier than the onset of cyclin B1 reduction. 
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It is unclear why these differing patterns of onset and duration occurred.  The molecular 
mechanisms underlying the G2/M arrest and the reasons for the variation in the timing of cyclin 
B1 reductions following radiation are still relatively unknown, and seemingly contradictory 
reports exist in the literature.  For example, some studies have shown that a decline in cyclin B1 
levels is often observed before cells start accumulating into G2/M phase (161).  These reports 
would be in agreement with our observations on A375 cells following 5 and 100 cGy and PC3 
cells following 50 and 100 cGy.  Studies have shown that reduced cyclin B1 levels can occur 
concurrent with the onset G2/M accumulation, as is seen in our studies following A375 cells 
irradiated with 2 and  50 cGy (161).  Finally, reports have suggested that cyclin B1 levels may be 
be down regulated following accumulation of cells in G2/M, such as we observed in PC3 cells 
following 50 cGy irradiation (159).  Obviously, more studies are needed to elucidate 
mechanisms underlying the onset and duration of G2/M arrest. 
Finally, since levels of cyclin B1 are extremely low in G0/G1 and S phases (refer to 
Figure 1.2, Chapter 1), reduction in cyclin B1 levels may not only correlate with the presence of 
a G2/M block, but also can be observed in situations where a large cohort of the cells are in 
G0/G1 or S phases of the cell cycle, such as would be observed in a synchronized population.  In 
this regards, the significant decreases in cyclin B1 levels seen in the A375 cells at 24 hours after 
2, 5, 50 and 100 cGy of irradiation, and in the PC3 cells at 24 hours after 50 and 100 cGy of 
irradiation is further indication of synchronization, or, at least, partial synchronization of these 
two cell populations at this time. Synchronization or partial synchronization following exposure 
to x-rays has been observed by many radiation workers in both in-vivo and in-vitro conditions 
(151-153).  
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4.4 MAPK RESPONSE IN A375 AND PC3 CELLS AT LOW DOSES OF RADIATION 
Numerous studies have shown that radiation can activate a variety of tyrosine kinase 
receptors, leading to activation of the family of serine-threonine kinases, known as MAP kinases 
(for a review see(163) and triggering of the ras-MAPK pathway (also known as the extracellular 
signal-regulated kinase 1 and 2 or ERK1/2 pathway), the c-jun NH2-terminal kinase (JNK) 
pathway, and (3) the p38 MAPK (100, 164-166).  Radiation-induced EKR1/2 has been 
demonstrated to be associated with signals that promote cell survival and inhibit apoptosis (79), 
and, hence, may be involved in cellular radioresistance such as that observed in the A375 cell 
studies in this investigation.  In contrast, activated JNK1/2 is capable of phosphorylating the 
NH2- terminal sites in c-Jun and c-Myc, leading to cell apoptotic death (61, 88), and, hence, may 
be involved in cellular radiosensitivity such as that observed in the PC3 cell studies.  Finally, 
activation of the p38 MAPK pathway has been documented to have contradictory effects, 
promoting both cell survival and cell death (108, 109), and, therefore, may be play a role in both 
of the differential radiation responses observed in these studies.  Given the role that the MAPK 
kinases may play in radiation response, therefore, it was of interest to determine if the hyper-
radioresistance seen in A375 cells and/or the hyper-radiosensitivity observed in PC3 cells 
following exposure to 2 and 5 cGy doses could be linked to activation of one or more of these 
pathways.  Unfortunately, in these studies, no significant changes in the activation of these 
pathways appeared to occur following very low dose irradiation exposures.   Only a limited 
number of investigations have focused on the activation of these pathways following very low 
dose radiation, and, at odds with the results of this study, the majority of these studies suggest 
that low doses of radiation can stimulate proliferation or survival through activation of either 
ERK1/2 or p38.  For example, Suzuki et al  reported induction of hyperproliferation in HE49 
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normal human diploid cells via activation of ERK1/2 (19), and Kim et al demonstrated 
enhancement of cell proliferation  following 5 cGy, via transient activation of  ERK1/2 and p38 
in CCD 18Lu normal human lung fibroblasts (20).  It is unclear why the results of these studies 
differ from other studies, but it may involve differences in the cell lines used or the experimental 
assays and design.  Indeed, several studies have shown that response to very low dose radiation 
can be highly cell type specific (reviewed in (167)). 
Though MAPK changes are not linked to the differential radioreponses observed in these 
two cell lines following exposure to very low dose radiation, the data did show an increase in 
activation of ERK1/2 with increasing dose in both the PC3 and A375 cells following exposure to 
doses of 25 to 100 cGy. This is in agreement with other studies that have demonstrated that 
activation of ERK1/2 increases proportionally with increasing dose (77, 168).  
 
4.5 NF-B RESPONSE IN A375 AND PC3 CELLS AFTER LOW DOSE RADIATION 
Similar to the MAPK pathway studies described above, the goal of these studies was to 
determine if changes in the activation of NF-κB in A375 and PC3 cells could be correlated with 
the differential radioresponse to very low dose radiation exposures observed in this investigation. 
However results show that there are no significant radiation-induced changes in activated NF-kB 
for either cell line that correlate with observed radioresponse within the very low dose range of 
radiation (i.e.  hyper-radioresistance  in A375  and hyper-radiosensitivity in PC3).  Hence, it does 
not appear from these studies, that these differential radioresponses are associated with activation 
of the NF-κB pathway. 
Several researchers have demonstrated that radiation can activate NF-κB (115, 123), but 
the pattern and magnitude of this activation has varied greatly from study to study, depending on 
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the cell line investigated and the experimental conditions used. For example, in U1-Mel human 
melanoma cells, a steady increase in activation of NF-κB was observed from 0 to 4.5 Gy, after 
which activation fell gradually with increasing dose (122).  However, in the KG-human myeloid 
cell line, NF-κB was increasingly activated by ionizing radiation from 2 Gy onward, peaking at 
doses between 5 to 20 Gy (123).  Futhermore, while studies investigating the response of NF-κB 
pathway to low doses of radiation are limited, Mohan et al reported activation of NF-κB in 
human EBV-transformed 244B human lymphoblastoid cells irradiated with 0.25 to 2 Gy with a 
maximum activation at 50 cGy (124).  The results of this study differ significantly from these 
findings, in that no significant activation of NF-κB is present at any dose studied in the PC3 cell 
line except at 5 cGy where a significant decrease is seen, and, in the A375 cell line, data suggest 
at 10-50 cGy, activation of NF-κB is also decreased.  As with the MAPK studies, the reasons 
underlying the differences between these findings and other reported studies may be because 
individual cell lines respond to low dose radiation differently or it could be due to variations in 
experimental design.  
 
4.6 CONCLUSIONS 
The results of these studies demonstrate two different survival responses to very low dose 
irradiation (hyper-radioresistance in human A375 cells vs. hyper-radiosensitivity in human PC3 
cells).  As such, these results add to the increasing body of evidence which postulates that the 
cellular response to radiation at very low doses cannot simply be extrapolated back from the 
responses observed in the dose range used in classical cell survival studies.  Rather, response to 
very low dose irradiation is often contradictory and cell type specific.  
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Furthermore, the differences in G2/M arrest observed from both the frequency 
distribution and the cyclin B1 studies suggest that a differential regulation of cell cycle signaling 
may be involved in the contradictory survival responses observed in these two cell lines. 
Specifically, there is correlation between the increased radiosensitivity observed in PC3 cells at 
very low radiation exposure and a failure of these cells to accumulate in G2/M following 
irradiation, and this correlation may suggest that failure to activate the G2 checkpoint could be a 
potential mechanism for very low dose hyper-radiosensitivity.  Conversely, the strong G2/M 
block observed in the A375 cells at doses of 2 and 5 cGy may contribute, at least in part, to the 
hyper-radioresistance seen in this cell line at this dose range.   
Finally, lack of significant changes in the levels of MAPK and NF-kB pathway markers 
for either cell line following exposures to very low dose range radiation, suggests that the hyper-
radioresistance seen in A375 cells and the hyper-radiosensitivity seen in PC3 cells at 2 and 5 cGy 
is not correlated with the activation of these regulatory pathways. 
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